
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-manuscript.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A45000054900249A5B6.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="nihpa" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC7004873/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004873/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Cell metabolism" /><meta name="citation_title" content="Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids" /><meta name="citation_author" content="Sarah E. LeBoeuf" /><meta name="citation_author_institution" content="Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA." /><meta name="citation_author" content="Warren L. Wu" /><meta name="citation_author_institution" content="Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA." /><meta name="citation_author" content="Triantafyllia R. Karakousi" /><meta name="citation_author_institution" content="Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA." /><meta name="citation_author" content="Burcu Karadal" /><meta name="citation_author_institution" content="Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA." /><meta name="citation_author" content="S. RaElle Jackson" /><meta name="citation_author_institution" content="Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA" /><meta name="citation_author" content="Shawn M. Davidson" /><meta name="citation_author_institution" content="Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA" /><meta name="citation_author_institution" content="Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA" /><meta name="citation_author" content="Kwok-kin Wong" /><meta name="citation_author_institution" content="Division of Hematology &#x00026; Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA" /><meta name="citation_author" content="Sergei B. Koralov" /><meta name="citation_author_institution" content="Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA." /><meta name="citation_author" content="Volkan I. Sayin" /><meta name="citation_author_institution" content="Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, SE-405 30 Gothenburg, Sweden" /><meta name="citation_author_institution" content="Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden." /><meta name="citation_author" content="Thales Papagiannakopoulos" /><meta name="citation_author_institution" content="Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA." /><meta name="citation_author_institution" content="Lead Contact" /><meta name="citation_publication_date" content="2020/02/02" /><meta name="citation_issue" content="2" /><meta name="citation_volume" content="31" /><meta name="citation_firstpage" content="339" /><meta name="citation_doi" content="10.1016/j.cmet.2019.11.012" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC7004873/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC7004873/" /><meta name="citation_pmid" content="31813821" /><meta name="DC.Title" content="Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Sarah E. LeBoeuf" /><meta name="DC.Contributor" content="Warren L. Wu" /><meta name="DC.Contributor" content="Triantafyllia R. Karakousi" /><meta name="DC.Contributor" content="Burcu Karadal" /><meta name="DC.Contributor" content="S. RaElle Jackson" /><meta name="DC.Contributor" content="Shawn M. Davidson" /><meta name="DC.Contributor" content="Kwok-kin Wong" /><meta name="DC.Contributor" content="Sergei B. Koralov" /><meta name="DC.Contributor" content="Volkan I. Sayin" /><meta name="DC.Contributor" content="Thales Papagiannakopoulos" /><meta name="DC.Date" content="2020 Feb 4" /><meta name="DC.Identifier" content="10.1016/j.cmet.2019.11.012" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids" /><meta property="og:type" content="article" /><meta property="og:description" content="Rewiring of metabolic pathways is a hallmark of tumorigenesis as cancer cells acquire novel nutrient dependencies to support oncogenic growth. A major genetic subtype of lung adenocarcinoma with KEAP1/NRF2-mutations, which activate the endogenous oxidative ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004873/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7004873/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7004873
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC7004873/pdf/nihms-1545176.pdf" class="int-view">PDF (2.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7004873/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7004873/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="7004873" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004873%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="Q9sl4ZCuc7jLOvrf7ypPTyEK353Wd4G5qdkC4P3eurSDIFW47Ejo0qWQZxfdCIWv">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004873%2F&amp;text=Activation%20of%20oxidative%20stress%20response%20in%20cancer%20generates%20a%20druggable%20dependency%20on%20exogenous%20non-essential%20amino%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004873%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004873/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7004873/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/31813821/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7004873/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/31813821/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7004873/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7004873/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC7004873
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-nihpa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.hhs.gov/open/public-access-guiding-principles/index.html" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div><span id="pmcmata">Cell Metab.</span> Author manuscript; available in PMC 2021 Feb 4.</div><div></div><div class="final-form"><em>Published in final edited form as:</em></div><div class="final-citation"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=31813821" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Cell Metab. 2020 Feb 4; 31(2): 339–350.e4. </a></div><span class="fm-vol-iss-date">Published online 2019 Dec 5. </span> <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.cmet.2019.11.012" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.cmet.2019.11.012</a></span></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC7004873</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS1545176</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31813821">31813821</a></div></div></div><h1 class="content-title">Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=LeBoeuf%20SE%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838567685760" co-class="co-affbox">Sarah E. LeBoeuf</a>,<sup>1,</sup><sup>#</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20WL%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838567670832" co-class="co-affbox">Warren L. Wu</a>,<sup>1,</sup><sup>#</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Karakousi%20TR%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838567668528" co-class="co-affbox">Triantafyllia R. Karakousi</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Karadal%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838567666768" co-class="co-affbox">Burcu Karadal</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jackson%20SR%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838567664816" co-class="co-affbox">S. RaElle Jackson</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Davidson%20SM%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838567662576" co-class="co-affbox">Shawn M. Davidson</a>,<sup>2,</sup><sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wong%20Kk%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838570014160" co-class="co-affbox">Kwok-kin Wong</a>,<sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Koralov%20SB%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838570011920" co-class="co-affbox">Sergei B. Koralov</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sayin%20VI%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838570009744" co-class="co-affbox">Volkan I. Sayin</a>,<sup>5,</sup><sup>6</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Papagiannakopoulos%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm139838570006640" co-class="co-affbox">Thales Papagiannakopoulos</a><sup>1,</sup><sup>7,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139838567685760"><h3 class="no_margin">Sarah E. LeBoeuf</h3><p><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=LeBoeuf%20SE%5BAuthor%5D">Sarah E. LeBoeuf</a></div></div><div id="_co_idm139838567670832"><h3 class="no_margin">Warren L. Wu</h3><p><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20WL%5BAuthor%5D">Warren L. Wu</a></div></div><div id="_co_idm139838567668528"><h3 class="no_margin">Triantafyllia R. Karakousi</h3><p><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Karakousi%20TR%5BAuthor%5D">Triantafyllia R. Karakousi</a></div></div><div id="_co_idm139838567666768"><h3 class="no_margin">Burcu Karadal</h3><p><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Karadal%20B%5BAuthor%5D">Burcu Karadal</a></div></div><div id="_co_idm139838567664816"><h3 class="no_margin">S. RaElle Jackson</h3><p><sup>2</sup>Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jackson%20SR%5BAuthor%5D">S. RaElle Jackson</a></div></div><div id="_co_idm139838567662576"><h3 class="no_margin">Shawn M. Davidson</h3><p><sup>2</sup>Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA</p><p><sup>3</sup>Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Davidson%20SM%5BAuthor%5D">Shawn M. Davidson</a></div></div><div id="_co_idm139838570014160"><h3 class="no_margin">Kwok-kin Wong</h3><p><sup>4</sup>Division of Hematology &#x00026; Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wong%20Kk%5BAuthor%5D">Kwok-kin Wong</a></div></div><div id="_co_idm139838570011920"><h3 class="no_margin">Sergei B. Koralov</h3><p><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Koralov%20SB%5BAuthor%5D">Sergei B. Koralov</a></div></div><div id="_co_idm139838570009744"><h3 class="no_margin">Volkan I. Sayin</h3><p><sup>5</sup>Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, SE-405 30 Gothenburg, Sweden</p><p><sup>6</sup>Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden.</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Sayin%20VI%5BAuthor%5D">Volkan I. Sayin</a></div></div><div id="_co_idm139838570006640"><h3 class="no_margin">Thales Papagiannakopoulos</h3><p><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</p><p><sup>7</sup>Lead Contact</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Papagiannakopoulos%20T%5BAuthor%5D">Thales Papagiannakopoulos</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm139838573108352_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139838573108352_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm139838573108352_ai" style="display:none"><div class="fm-affl" id="A1"><sup>1</sup>Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.</div><div class="fm-affl" id="A2"><sup>2</sup>Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA</div><div class="fm-affl" id="A3"><sup>3</sup>Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA</div><div class="fm-affl" id="A4"><sup>4</sup>Division of Hematology &#x00026; Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA</div><div class="fm-affl" id="A5"><sup>5</sup>Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, SE-405 30 Gothenburg, Sweden</div><div class="fm-affl" id="A6"><sup>6</sup>Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden.</div><div class="fm-affl" id="A7"><sup>7</sup>Lead Contact</div><div><p id="P1" class="p p-first">Author Contributions</p>Conceptualization and Methodology, S.E.L., W.L.W, and T.P.; Investigation, S.E.L., W.L.W., T.R.K., B.K., S.R.J., S.M.D, and V.I.S.; Writing &#x02013; Original Draft, S.E.L. and T.P.; Visualization, S.E.L.; Supervision, K.W., S.B.K., and T.P.; Funding Acquisition, T.P.; Writing &#x02013; Review &#x00026; Editing, all authors.</div><div id="FN2"><sup>#</sup>These authors contributed equally to this work</div><div id="CR2"><sup>*</sup>to whom correspondence should be addressed: <a href="mailto:dev@null" data-email="gro.cmuyn@10tgapap" class="oemail">gro.cmuyn@10tgapap</a></div></div><div class="fm-article-notes half_rhythm"></div><div class="permissions half_rhythm hide" id="idm139838573108352_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">PMC Copyright notice</a> </div><div><a href="#FN3">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm" role="complementary" aria-label="Related or updated information about this article."><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=31813821" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Cell Metab</a></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>2.</strong></div><div><a href="/pmc/articles/PMC7004873/bin/NIHMS1545176-supplement-2.pdf" data-ga-action="click_feat_suppl">NIHMS1545176-supplement-2.pdf</a><span style="color:gray"> (78M)</span></div><div class="small guid">GUID: 1EF70CCE-E5EC-4C6D-860F-07DAEA9CBA6C</div></div></dd></dl><dl data-length="56" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">This study did not generate any unique datasets or code.</p></dd></dl></div><div id="ABS1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="ABS1title">Summary</h2><!--article-meta--><div><p id="P3" class="p p-first-last">Rewiring of metabolic pathways is a hallmark of tumorigenesis as cancer cells acquire novel nutrient dependencies to support oncogenic growth. A major genetic subtype of lung adenocarcinoma with <em>KEAP1/NRF2</em>-mutations, which activate the endogenous oxidative stress response, undergo significant metabolic rewiring to support enhanced antioxidant production. We demonstrate that cancers with high antioxidant capacity exhibit a general dependency on exogenous non-essential amino acids (NEAAs) that is driven by the Nrf2-dependent secretion of glutamate through system x<sub>c</sub><sup>&#x02212;</sup>(XCT), which limits intracellular glutamate pools that are required for NEAA synthesis. This dependency can be therapeutically targeted by dietary restriction or enzymatic depletion of individual NEAAs. Importantly, limiting endogenous glutamate levels by glutaminase inhibition can sensitize tumors without alterations in Keap1/Nrf2 pathway to dietary restriction of NEAAs. Our findings identify a metabolic strategy to therapeutically target cancers with genetic or pharmacologic activation of the Nrf2 antioxidant response pathway by restricting exogenous sources of NEAAs.</p></div></div><div id="ABS2" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="ABS2title">Graphical Abstract</h2><!--article-meta--><div><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838610586800"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0001.jpg" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0001.jpg" /></div><p></p></div></div><div id="ABS3" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="ABS3title">eTOC</h2><!--article-meta--><div><p id="P5" class="p p-first-last">LeBoeuf <em>et al.</em> describe a general mechanism through which cancer cells depend on non-essential amino acids. Tumor cells with intrinsically low intracellular glutamate require amino acids to be supplied from the extracellular environment. By reducing the amount of circulating amino acids, the authors reduce tumor growth <em>in vivo</em>.</p></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">Introduction</h2><p id="P6" class="p p-first"><em>NFE2L2</em> (hereafter <em>NRF2</em>) is the master transcriptional regulator of the cell&#x02019;s antioxidant response. Nrf2 controls the transcription of a plethora of genes involved in the detoxification of reactive oxygen species (ROS). Under normal conditions Nrf2 is sequestered in the cytoplasm and targeted for proteasomal degradation through its interaction with Kelch-like ECH-associated protein 1 (hereafter Keap1). In the presence of ROS, key cystine residues on Keap1 are oxidized resulting in a conformational change which intern disrupts its interaction with Nrf2, allowing Nrf2 to translocate to the nucleus where it promotes transcription of target genes. <em>KEAP1</em> or <em>NRF2</em> are mutated in approximately 20% of KRAS-driven non-small-cell lung cancer (NSCLC), one of the most aggressive lung cancer subtypes, and therefore a major therapeutic target (<a href="#R5" rid="R5" class=" bibr popnode">Cronin et al., 2018</a>). Additionally, mutations in the KEAP1/NRF2 antioxidant signaling pathway are common events in several solid cancers and are associated with poor patient prognosis and outcomes (<a href="#R3" rid="R3" class=" bibr popnode">Cancer Genome Atlas Research, 2012</a>, <a href="#R4" rid="R4" class=" bibr popnode">2014</a>; <a href="#R28" rid="R28" class=" bibr popnode">Kovac et al., 2015</a>). Loss of KEAP1 and subsequent stabilization of NRF2 leads to metabolic reprogramming in order to promote the endogenous antioxidant response, which confers proliferative and survival advantages to tumor cells (<a href="#R12" rid="R12" class=" bibr popnode">DeNicola et al., 2011</a>; <a href="#R40" rid="R40" class=" bibr popnode">Mitsuishi et al., 2012</a>; <a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). However, maintaining oxidative homeostasis through chronic activation of the NRF2 pathway results in a unique set of metabolic requirements to support increased antioxidant capacity (<a href="#R11" rid="R11" class=" bibr popnode">DeNicola et al., 2015</a>; <a href="#R27" rid="R27" class=" bibr popnode">Koppula et al., 2017</a>; <a href="#R40" rid="R40" class=" bibr popnode">Mitsuishi et al., 2012</a>; <a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). Previous work from our group has shown that <em>KEAP1/NRF2</em>-mutant tumors are dependent on exogenous glutamine to sustain proliferation (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). This dependency is due to two major transcriptional outputs of NRF2: 1) the consumption of glutamine-derived glutamate for glutathione (GSH) synthesis; and 2) the efflux of glutamate through system x<sub>c</sub><sup>&#x02212;</sup>, in exchange for cystine, the major source of cysteine for most cancer cells (<a href="#R41" rid="R41" class=" bibr popnode">Muir et al., 2017</a>; <a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>; <a href="#R49" rid="R49" class=" bibr popnode">Shin et al., 2017</a>). Depletion of endogenous glutamate pools due to high efflux through system x<sub>c</sub><sup>&#x02212;</sup> compromises the use of glutamate as a carbon source for TCA cycle anaplerosis (<a href="#R18" rid="R18" class=" bibr popnode">Fox et al., 2019</a>; <a href="#R27" rid="R27" class=" bibr popnode">Koppula et al., 2017</a>; <a href="#R41" rid="R41" class=" bibr popnode">Muir et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>; <a href="#R49" rid="R49" class=" bibr popnode">Shin et al., 2017</a>).</p><p id="P7">In addition to supplying carbon to fuel central carbon metabolism, glutamate is a critical nitrogen donor for transamination reactions which catalyze the synthesis of NEAAs (<a href="#R9" rid="R9" class=" bibr popnode">DeBerardinis et al., 2007</a>; <a href="#R54" rid="R54" class=" bibr popnode">Umbarger, 1978</a>). NEAAs can be synthesized by cells <em>de novo</em> when their availability becomes limited. However, because of high proliferative capacity and increased metabolic output, many cancer cells become dependent on the exogenous supply of certain metabolites such as NEAAs, and synthesis is not adequate to keep up with demand (<a href="#R53" rid="R53" class=" bibr popnode">Tsun and Possemato, 2015</a>). Although <em>KEAP1/NRF2</em>-mutations lead to a reliance on exogenous glutamine to supply glutamate, it remains unclear how other glutamate-dependent biosynthetic reactions, such as NEAA synthesis, are affected by this altered metabolic state where glutamate is actively secreted through system xc<sup>&#x02212;</sup>. Although most studies have focused on understanding how individual amino acids contribute to tumorigenesis, it remains elusive whether genetic alterations that promote tumor formation can rewire metabolism to generate a more general requirement for exogenous sources of NEAAs.</p><p id="P8" class="p p-last">Here we show that mutations in <em>KEAP1</em> confer a dependency on exogenous uptake of multiple NEAAs in Kras-driven cell lines. We demonstrate that <em>KEAP1</em> mutant cells have increased uptake of NEAAs and are sensitive to deprivation of asparagine, glycine and serine <em>in vitro</em> and <em>in vivo</em>. Despite their ability to synthesize NEAAs, <em>KEAP1</em> mutant cells are unable to maintain sufficient amino acids pools by <em>de novo</em> synthesis under NEAA deprivation conditions. Blocking the efflux of glutamate thereby increasing intracellular glutamate levels through system x<sub>c</sub><sup>&#x02212;</sup> inhibition is sufficient to rescue amino acid synthesis and cell proliferation under NEAA deprivation conditions. Furthermore, these phenotypes are Nrf2-dependent and can be acutely induced by use of a small molecule activator of Nrf2 or by chronic ROS-dependent post-translational activation of Nrf2 in Keap1 wildtype adenocarcinomas originating from both lung and pancreas. Importantly, we show that by pharmacologic or Nrf2-dependent restriction of intracellular glutamate, we can suppress tumor growth by either dietary or enzymatic depletion of NEAAs <em>in vivo</em>. Together our data provides evidence for a general mechanism by which intracellular glutamate availability dictates the dependency of cancer cells on exogenously supplied NEAAs and this dependency may be therapeutically exploited through pharmacologic or dietary intervention.</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">Results</h2><div id="S3" class="sec sec-first"><h3 id="S3title">KEAP1 loss increases dependency on exogenous supply of NEAAs</h3><p id="P9" class="p p-first"><em>KEAP1</em> mutations accelerate tumor progression (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>) and result in metabolic reprograming of cancer cells (<a href="#R11" rid="R11" class=" bibr popnode">DeNicola et al., 2015</a>; <a href="#R27" rid="R27" class=" bibr popnode">Koppula et al., 2017</a>; <a href="#R40" rid="R40" class=" bibr popnode">Mitsuishi et al., 2012</a>; <a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>), including depletion of intracellular glutamate levels. We reasoned that <em>KEAP1</em> mutant tumors may possess an impaired ability to synthesize NEAAs and are more reliant on exogenous sources to sustain amino acid pools. In order to identify differential amino acid requirements in tumors carrying <em>KEAP1</em> mutations we profiled <em>in vitro</em> uptake rates of NEAAs between isogenic mouse Kras<sup>G12D/+</sup>; p53<sup>&#x02212;/&#x02212;</sup> mutant lung adenocarcinoma cell lines that are either wildtype (Wt) or <em>Keap1</em> null (Mut) (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>). Indeed, <em>Keap1</em> mutant cells exhibited increased uptake of a number of NEAAs including asparagine, glutamine, alanine, and glycine when compared to <em>Keap1</em> wild-type cells (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1a</span></a>). Using [UC<sup>13</sup>]-L-serine, we confirmed <em>Keap1</em> mutant cells uptake significantly more serine compared to <em>Keap1</em> wildtype cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 1a</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838567624640"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7004873_nihms-1545176-f0002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139838567624640"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC7004873/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>Keap1</em> loss increases dependency on exogenous supply of NEAAs</strong><p id="P62"><strong>a)</strong>
<em>In vitro</em> uptake assay of amino acids after 24 hours <strong>b)</strong> Serum levels of asparagine, glycine and serine in mice bearing subcutaneous tumors. <strong>c)</strong> Proliferation in media lacking specified amino acid. <strong>d)</strong> Relative viability of cells cultured treated with L-asparaginase for 3 days. <strong>e)</strong> Proliferation of wildtype (Wt) or <em>Keap1</em> mutant (Mut) LKR (Kras<sup>G12D/+</sup>;p53<sup>+/+</sup>) cell lines in media lacking serine or asparagine. <strong>f)</strong> Proliferation of cells expressing an empty vector or WT Keap1 in RPMI lacking serine or asparagine. <strong>g)</strong> Schematic depicting synthesis of serine from glucose (top) and asparagine from glutamine (bottom). Filled blue circles represent <sup>13</sup>C atoms derived from [U<sup>13</sup>C]-D-glucose or [U<sup>13</sup>C]-L-glutamine. <strong>h)</strong> Mass isotopomer analysis of serine and asparagine in cells cultured in complete or amino acid deprived conditions. *p&#x0003c;0.05, **p&#x0003c;0.01, ***p&#x0003c;0.001, ****p&#x0003c;0.0001.</p></div></div></div><p id="P11">While <em>Keap1</em> mutant cells uptake more NEAAs <em>in vitro</em>, cell metabolism can be drastically different <em>in vivo</em> (<a href="#R7" rid="R7" class=" bibr popnode">Davidson et al., 2016</a>). To assess whether the increased uptake of NEAAs <em>in vitro</em> by <em>Keap1</em> mutant cells is physiologically relevant <em>in vivo</em>, we subcutaneously transplanted wildtype and <em>Keap1</em> mutant cells in C57B6/J syngeneic animals and monitored the levels of NEAAs in serum and tumors. We observed that mice bearing <em>Keap1</em> mutant tumors had decreased serum levels of multiple NEAAs, including serine and glycine (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1b</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 1b</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">c</a>).</p><p id="P12">To assess whether this increased uptake of NEAAs is functionally relevant for the growth of <em>Keap1</em> mutant cells, we depleted individual NEAAs from the media and observed marked growth suppression of <em>Keap1</em> mutant cells upon depletion of asparagine, serine and glycine (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1c</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 1d</a>). Alanine, another highly consumed NEAA (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1a</span></a>) could not be depleted from the media (present in serum but not in DMEM or RPMI). However, supplementation of alanine to <em>Keap1</em> mutant cells led to an increase in proliferation (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 1e</a>). Additionally, <em>Keap1</em> mutant cells showed increased sensitivity to L-asparaginase (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1d</span></a>), a recombinant enzyme that catalyzes the degradation of asparagine to glutamate and aspartate, which is currently used for the treatment of acute lymphoblastic leukemia (<a href="#R45" rid="R45" class=" bibr popnode">Richards and Kilberg, 2006</a>).</p><p id="P13">The genetic status of <em>Trp53</em> has been previously shown to characterize dependency on exogenous serine (<a href="#R35" rid="R35" class=" bibr popnode">Maddocks et al., 2013</a>). To exclude the possibility that the observed dependency of <em>Keap1</em> mutant cells on exogenous NEAAs is driven by loss of p53, we used <em>Kras</em><sup><em>G12D</em></sup> mutant lung adenocarcinoma cell lines with wildtype <em>p53</em> (<em>Kras</em><sup><em>G12D/+</em></sup><em>; p53</em><sup><em>+/+</em></sup>; LKR10 and LKR13; (<a href="#R39" rid="R39" class=" bibr popnode">Meylan et al., 2009</a>)) that were either wildtype or mutant for <em>Keap1</em> (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>). Consistent with our data in <em>p53</em> null, <em>Keap1</em> wildtype cells, we observed that <em>Keap1</em> loss increased uptake of NEAAs (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 1f</a>) and rendered <em>p53</em> wildtype cells sensitive to both serine and asparagine deprivation (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1e</span></a>). Additionally, genetic complementation of <em>Keap1</em> by over-expression of wildtype Keap1 cDNA in <em>Keap1</em> null cell lines, was sufficient to rescue sensitivity to serine and asparagine depletion (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1f</span></a>), confirming that sensitivity to NEAA depletion is dependent on <em>Keap1</em> loss. Similar, to mouse cells, human <em>KEAP1</em> mutant lung adenocarcinoma cell lines were more sensitive to serine deprivation than <em>KEAP1</em> wildtype cell lines (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 1g</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">h</a>) despite having other driver mutations. Taken together, these results indicate that Nrf2-activation generates a dependency on exogenous uptake of multiple NEAAs independent of the genetic status of <em>Kras</em> or <em>p53</em>.</p><p id="P14" class="p p-last">We hypothesized that the increased uptake of NEAAs may be a result of increased basal demand in <em>Keap1</em> mutant cells, and when exogenous NEAAs are depleted from the culture media, rates of <em>de novo</em> synthesis in <em>Keap1</em> mutant are insufficient to sustain cellular proliferation. To test this hypothesis, we performed stable isotope tracing with [UC<sup>13</sup>]-D glucose and [UC<sup>13</sup>]-L glutamine to assess synthesis of NEAAs in replete as well as serine or asparagine deprived conditions (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1g</span></a>). We observe that when serine or asparagine are depleted from the culture media, rates of NEAA synthesis are roughly equivalent between <em>Keap1</em> mutant and 6 wildtype cells (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1h</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 2a</a> &#x02013; <a href="#SD1" rid="SD1" class=" supplementary-material">c</a>) indicating that wildtype and <em>Keap1</em> mutant cells have roughly the equivalent capacity to synthesize serine when necessary. However, when serine or asparagine are removed from the media the total pool of these metabolites is significantly reduced in <em>Keap1</em> mutant compared to wildtype cells (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1h</span></a>) suggesting that <em>de novo</em> synthesis in <em>Keap1</em> mutant cells is unable to maintain adequate pools of these metabolites to sustain proliferation (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1c</span></a>). Additionally, in the case of serine, we observe that in complete media the total intracellular pool of serine in <em>Keap1</em> mutant cells is much larger than in wildtype cells (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1h</span></a>). This suggests that <em>Keap1</em> mutant cells have an increased requirement for serine. These findings are consistent with the idea that to support growth and increased anabolism, <em>Keap1</em> mutant cells rely on uptake of exogenous NEAAs.</p></div><div id="S4" class="sec"><h3 id="S4title">Acute activation of Nrf2 induces dependency on NEAAs</h3><p id="P15" class="p p-first">Given that genetic activation of Nrf2 in <em>Keap1</em> mutant cells leads to a dependency on exogenous serine and asparagine, we hypothesized that pharmacological dependent stabilization of Nrf2 may lead to a similar metabolic demand. Indeed, we observed that acute activation of Nrf2 with a small molecule activator (KI696) (<a href="#R8" rid="R8" class=" bibr popnode">Davies et al., 2016</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>) led to suppression of growth upon deprivation of serine or asparagine (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 2d</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">e</a>) or treatment with L-asparaginase (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 2f</a>). Furthermore, to ensure this is not a cell line specific phenomenon we used a panel of five different murine Kras<sup>G12D/+</sup>; p53<sup>&#x02212;/&#x02212;</sup> lung adenocarcinoma cell lines and demonstrated that small molecule induced activation of Nrf2 led to a dependency on exogenous serine and asparagine (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2a</span></a>). Similarly, dependency on exogenous NEAAs was independent of p53 status as Nrf2 activation in <em>p53</em> wildtype LKR lines lead to growth suppression in serine or asparagine depleted conditions (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838573171120"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7004873_nihms-1545176-f0003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139838573171120"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC7004873/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Acute activation of Nrf2 induces dependency on NEAAs</strong><p id="P63"><strong>a)</strong> Proliferation of wildtype (Kras<sup>G12D/+</sup>; p53<sup>&#x02212;/&#x02212;</sup>) murine LUAD tumor cell lines in the absence of serine or asparagine. <strong>b)</strong> Proliferation of <em>Keap1</em> wildtype LKR (Kras<sup>G12D/+</sup>;p53<sup>+/+</sup>) cell lines in media lacking serine or asparagine. <strong>c)</strong> Proliferation of wildtype murine Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup> pancreatic cancer cell line in media lacking serine. <strong>d)</strong> Relative viability of <em>Keap1</em> wildtype murine Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup> pancreatic cancer cell line treated with L-asparaginase. <strong>e)</strong> Schematic depicting mechanism of action of oxidants used to activate Nrf2. <strong>f)</strong> Proliferation of wildtype cells in media lacking serine or asparagine after oxidant treatment. *p&#x0003c;0.05, **p&#x0003c;0.01, ***p&#x0003c;0.001, ****p&#x0003c;0.0001.</p></div></div></div><p id="P16">We have previously characterized the specificity of the small molecule activator, and validated that it only disrupts the binding of Keap1 to Nrf2 and does not affect interactions of other proteins with Keap1 (<a href="#R32" rid="R32" class=" bibr popnode">Lignitto et al., 2019</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). However, we confirmed the small molecule does not induce sensitivity to NEAA deprivation independently of Nrf2 activity by treating <em>Nrf2</em> null cells. As expected, treatment with the Nrf2 activator only induced sensitivity in wildtype cells and had no effect on <em>Nrf2</em> null cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 2g</a>).</p><p id="P17" class="p p-last">Furthermore, we hypothesized that Nrf2 activation would lead to dependency on exogenous NEAAs independent of cancer subtype. To test this, we treated a murine Kras<sup>G12D/+</sup>; p53<sup>&#x02212;/&#x02212;</sup> pancreatic ductal adenocarcinoma cell line with the Nrf2 activator and observed robust growth suppression upon serine deprivation or treatment with L-asparaginase (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2c</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>d</span></a>).</p></div><div id="S5" class="sec"><h3 id="S5title">Oxidative stress sensitizes <em>Keap1</em> wildtype cells to NEAA deprivation</h3><p id="P18" class="p p-first-last">Our prior results demonstrate that activation of Nrf2 strongly sensitizes cells to NEAA depletion. In wildtype cells, Nrf2 is stabilized in response to ROS-dependent post-translational modifications of Keap1 and remains active until ROS are cleared. Therefore, we reasoned that during periods of chronic ROS stress, ROS would promote stabilization of Nrf2 in wildtype cells and would subsequently result in Nrf2-mediated metabolic rewiring. Therefore, when ROS is high, wildtype cells would efflux glutamate through system x<sub>c</sub><sup>&#x02212;</sup> and become sensitive to NEAA depletion, similar to <em>Keap1</em> mutant cells. To test this hypothesis, we treated wildtype cells with various oxidants that interfere with different arms of the endogenous anti-oxidant response and activate Nrf2. Using a Thioredoxin reductase (TxR) inhibitor (Auranofin) (<a href="#R55" rid="R55" class=" bibr popnode">Urig and Becker, 2006</a>), an inhibitor of GSH synthesis (L-buthionine-sulfoximine, BSO) (<a href="#R21" rid="R21" class=" bibr popnode">Griffith and Meister, 1979</a>) and a general oxidative stress agent that will react with free cysteines (di-methyl fumarate, DMF) (<a href="#R57" rid="R57" class=" bibr popnode">Wang et al., 2015</a>) we assessed whether <em>Keap1</em> wildtype cells would become dependent on exogenous NEAAs (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2e</span></a>). We validated that treatment with all three oxidants resulted in stabilization of Nrf2 protein (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3a</a>) and induced expression of Nrf2 target genes (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3b</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">c</a>). Consistent with their mechanism of action, treatment with BSO and DMF also decreased GSH levels (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3d</a>). Indeed, we observed that ROS induced activation of Nrf2 by three different oxidative stress agents sensitized wildtype cells to NEAA depletion (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2f</span></a>).</p></div><div id="S6" class="sec"><h3 id="S6title">Low intracellular glutamate levels in cells with Nrf2 activation generates a dependency on exogenous NEAAs</h3><p id="P19" class="p p-first">NEAAs are synthesized from &#x003b1;-ketoacids to which an amino group is added via a glutamate or glutamine-dependent transamination reaction (<a href="#R30" rid="R30" class=" bibr popnode">Lehninger et al., 2000</a>). Previously, we have reported that Nrf2 activation leads to a marked decrease in intracellular glutamate by utilization of glutamate for glutathione synthesis and the secretion of glutamate through system x<sub>c</sub><sup>&#x02212;</sup> to enable cystine uptake (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). Given the increased dependency of cells with Nrf2 activation on exogenous NEAAs, we hypothesized that by increasing intracellular glutamate levels either by inhibiting system x<sub>c</sub><sup>&#x02212;</sup> or by expressing additional glutamate transporters (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3a</span></a>), we would enhance synthesis of NEAAs and decrease the dependency of <em>Keap1</em> mutant cells on exogenous NEAAs. To inhibit system x<sub>c</sub><sup>&#x02212;</sup> activity we either pretreated cells with the small molecule inhibitor Erastin (<a href="#R15" rid="R15" class=" bibr popnode">Dixon et al., 2014</a>) or high glutamate which forces the import of glutamate and export of cystine through system x<sub>c</sub><sup>&#x02212;</sup> in a concentration dependent manner (<a href="#R2" rid="R2" class=" bibr popnode">Briggs et al., 2016</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>; <a href="#R58" rid="R58" class=" bibr popnode">Watanabe and Bannai, 1987</a>). Both Erastin and glutamate treatment of <em>Keap1</em> mutant cells significantly increased intracellular glutamate levels (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3b</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>c</span></a>) and consequently decreased intracellular cystine levels (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3e</a>). Treatment with either Erastin or glutamate was able to completely rescue <em>Keap1</em> mutant cell growth when serine or asparagine were depleted (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3d</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>e</span></a>), or when cells were treated with L-asparaginase (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 3f</a>). In line with what we observed in murine lung adenocarcinoma, glutamate was also able to rescue sensitivity to NEAA depletion in a murine pancreatic ductal adenocarcinoma cell line after pharmacological activation of Nrf2 (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 3g</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838573164704"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7004873_nihms-1545176-f0004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139838573164704"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC7004873/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Low intracellular glutamate levels in cells with Nrf2 activation generates a dependency on exogenous NEAAs</strong><p id="P64"><strong>a)</strong> Schematic depicting modulation of intracellular glutamate levels. <strong>b and c)</strong> Relative intracellular abundance of glutamate in cells supplemented with glutamate or treated with Erastin. <strong>d and e)</strong> Proliferation of cells in media lacking serine or asparagine and supplemented with glutamate or Erastin. <strong>f)</strong> Relative metabolite flux of glutamate in cells expressing Slc1a3 or an empty vector. <strong>g and h)</strong> Proliferation of cells expressing Slc1a3 or an empty vector control in media lacking serine or asparagine. <strong>i and j)</strong> Relative viability of cells cultured in 0.1U/mL of L-Asparaginase or 10% the normal concentration of serine with increasing doses of CB-839. Data is represented as response to CB-839 treatment alone in media with 100% serine for each cell line. *p&#x0003c;0.05, **p&#x0003c;0.01, ***p&#x0003c;0.001, ****p&#x0003c;0.0001.</p></div></div></div><p id="P20">As a negatively charged amino acid, glutamate cannot freely diffuse across the plasma membrane and requires a dedicated transporter to enter the cell. To increase glutamate uptake, we over-expressed SLC1A3 (<a href="#R20" rid="R20" class=" bibr popnode">Garcia-Bermudez et al., 2018</a>), a glutamate transporter that is normally expressed in the central nervous system by glial cells (<a href="#R51" rid="R51" class=" bibr popnode">Storck et al., 1992</a>). In line with current literature, SLC1a3 was not expressed in our mouse LUAD cell lines, nor was its expression induced by pharmacologic or ROS mediated activation of Nrf2 or in response to NEAA depletion (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3h</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">i</a>). However, expression of SLC1A3 resulted in dramatic increase in the re-uptake of glutamate which is normally exported through system x<sub>c</sub><sup>&#x02212;</sup> (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3f</span></a>) and as expected, rescued sensitivity of <em>Keap1</em> mutant cells to glutaminase inhibition by CB-839 (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 3j</a>). Similar to treatment with glutamate or Erastin, expression of SLC1A3 rescued <em>Keap1</em> mutant cell growth when serine and asparagine were depleted (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3g</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>h</span></a>) or when treated with L-asparaginase (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 3k</a>).</p><p id="P21" class="p p-last">Previously, we have shown that <em>Keap1</em> mutant cells are highly sensitive to CB-839, a glutaminase inhibitor which blocks the conversion of glutamine to glutamate (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). Since increasing intracellular glutamate levels rescues cell growth when serine and asparagine are limited, we reasoned that CB-839 treatment should decrease glutamate availability and NEAA synthesis, and would further sensitize <em>Keap1</em> mutant cells to NEAA deprivation. We cultured cells in either 0.1U/mL of L-asparaginase or reduced the amount of serine in the media to 10% of its normal concentration. We observed increased sensitivity of <em>Keap1</em> mutant cells to very low doses of CB-839 (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3i</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>j</span></a>), which alone do not affect cell growth, suggesting possible synergistic effects of combining glutaminase treatment with NEAA deprivation. These results indicate that the increased efflux of glutamate by <em>Keap1</em> mutant cells generates a major bottleneck in their ability to sustain amino acid pools under NEAA deprived conditions and that intracellular glutamate levels determine a cell&#x02019;s dependency on exogenous NEAAs.</p></div><div id="S7" class="sec"><h3 id="S7title">Glutamate availability restricts serine biosynthesis</h3><p id="P22" class="p p-first">In addition to protein synthesis, serine and glycine are important carbon sources to generate nucleotides, methyl groups, other amino acids, and contribute to GSH synthesis (<a href="#R11" rid="R11" class=" bibr popnode">DeNicola et al., 2015</a>; <a href="#R38" rid="R38" class=" bibr popnode">Mehrmohamadi and Locasale, 2015</a>; <a href="#R61" rid="R61" class=" bibr popnode">Yang and Vousden, 2016</a>) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 4a</a>). To determine which of these metabolites is limiting during serine deprivation we tested if supplementation with antioxidants to restore redox buffering or nucleotides could rescue <em>Keap1</em> mutant cell growth in serine deprived conditions. Supplementation with the antioxidants N-acetylcysteine (NAC) or Trolox, did not rescue cell growth under serine deprivation (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4a</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 4b</a>). However, supplementation with formate, which rescues the one-carbon cycle, or thymidine, which rescues nucleotide synthesis, led to a complete rescue of cell growth in <em>Keap1</em> mutant cells under serine deprivation. This data suggests that nucleotide synthesis, and not antioxidant availability limits growth of <em>Keap1</em> mutant cells in serine depleted conditions.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838573155504"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7004873_nihms-1545176-f0005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139838573155504"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC7004873/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Glutamate availability restricts serine biosynthesis</strong><p id="P65"><strong>a)</strong> Proliferation of <em>Keap1</em> mutant cells in RPMI lacking serine and supplemented with antioxidants or downstream products of serine metabolism. <strong>b)</strong> Proliferation <em>Keap1</em> mutant cells expressing an sgRNA against PSAT in media lacking serine supplemented with formate, glutamate or Erastin. <strong>c)</strong> Schematic depicting serine synthesis from glucose. Filled blue circles represent <sup>13</sup>C atoms derived from [U<sup>13</sup>C]-D-glucose. <strong>d)</strong> Mass isotopomer analysis of serine and glycine in cells cultured without serine supplemented with glutamate or treated with CB-839. <strong>e)</strong> Schematic depicting serine synthesis from glucose utilizing an amino group from glutamate. Filled orange hexagons represent <sup>15</sup>N atoms derived from [&#x003b1;<sup>15</sup>N]-L-glutamine. <strong>f)</strong> Mass isotopomer analysis of serine and glycine in cells cultured in RPMI lacking serine. *p&#x0003c;0.05, **p&#x0003c;0.01, ****p&#x0003c;0.0001</p></div></div></div><p id="P23">Serine can be synthesized <em>de novo</em> from glucose in a multi-step reaction. Since, <em>Keap1</em> mutant cells have a reduced incorporation of glutamine into the TCA cycle, it is possible that <em>Keap1</em> mutant cells divert glucose into the TCA cycle to compensate, limiting glycolytic precursors for serine synthesis. Using [U-C<sup>13</sup>]-D-glucose we measured the incorporation of glucose derived carbon into the TCA cycle when cells were cultured in media lacking serine. Under these conditions we did not see an increase in glucose flux into the TCA cycle (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 4c</a>), suggesting that the availability of glycolytic precursors are not reduced in <em>Keap1</em> mutant cells. This agrees with our previous observations that under basal conditions, there is not an increased flux of glucose to the TCA cycle in <em>Keap1</em> mutant cells (<a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). Glutamine incorporation into the TCA cycle was also unchanged when serine was depleted (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 4c</a>). In addition to glucose, serine synthesis requires the nitrogen from the amino group of glutamate to be added to phosphohydroxypyruvate (PHP) to generate phosphor-serine and &#x003b1;-ketoglutarate (<a href="#R10" rid="R10" class=" bibr popnode">DeNicola and Cantley, 2015</a>). This transaminastion reaction is catalyzed by the enzyme phosphoserine aminotransferase (PSAT). We hypothesized that rescue of <em>Keap1</em> mutant cell growth in the absence of exogenous serine by Erastin or glutamate supplementation was due to increasing glutamate availability for serine biosynthesis. To test this, we generated PSAT knockout wildtype and <em>Keap1</em> mutant cells using CRISPR/Cas9. The ability of Erastin or glutamate to rescue cell growth in serine deprivation is dependent on the presence of PSAT (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4b</span></a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 4d</a>) suggesting that increasing intracellular glutamate levels rescues cell growth in the absence of serine by restoring serine biosynthesis.</p><p id="P24">To confirm that modulation of intracellular glutamate levels alters serine biosynthesis, we performed stable isotope tracing of [U<sup>13</sup>C]-D glucose in serine depleted conditions and looked for C<sup>13</sup> incorporation into newly synthesized serine and its downstream metabolite, glycine (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4c</span></a>). When glutamate availability is limited by treatment with CB-839 we see a decrease in both serine and glycine synthesis (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4d</span></a>). Conversely, when we increase intracellular glutamate by glutamate supplementation we observe an increase in both serine and glycine synthesis (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4d</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 4e</a>). To confirm that the nitrogen from glutamate is used for serine synthesis we cultured cells in the presence of [&#x003b1;<sup>15</sup>N]-L glutamine to determine the fate of the amino group of glutamate (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4e</span></a>). As expected, serine deprivation increases the incorporation of labeled nitrogen in both serine and glycine (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4f</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 4f</a>). Additionally, we see decreased incorporation of labeled nitrogen in <em>Keap1</em> mutant cells in serine deprived conditions (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4f</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 4f</a>) suggesting that diminished glutamate availability in <em>Keap1</em> mutant cells reduces serine synthesis. This is further supported by treating <em>Keap1</em> wildtype cells with a small molecule activator of Nrf2 which subsequently results in decreased incorporation of labeled nitrogen in serine and glycine (<a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4f</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 4g</a>).</p><p id="P25">In addition to glutamate availability, serine synthesis can be affected by redox balance (<a href="#R13" rid="R13" class=" bibr popnode">Diehl et al., 2019</a>; <a href="#R43" rid="R43" class=" bibr popnode">Reid et al., 2018</a>) and reduced TCA cycling as well as impaired mitochondrial function. We have previously supplemented <em>Keap1</em> mutant cells with dimethyl-&#x003b1;-ketoglutarate (DMG), a cell permeable form of &#x003b1;-ketoglutarate to improve TCA cycle function and increase abundance of TCA cycle intermediates. Supplementation with DMG rescued sensitivity to restriction of glutamine in the culture media as well as treatment with CB-839 (<a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). We supplemented <em>Keap1</em> mutant cells with DMG and observed a rescue in cellular proliferation in serine deprivation conditions (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 4h</a>). However, addition of DMG also increased glutamate availability in <em>Keap1</em> mutant cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 4i</a>). In a complementary approach we over expressed the yeast mitochondrial complex I protein, NDI1, in wildtype and <em>Keap1</em> mutant cells. Expression of NDI1 in mammalian cells improves mitochondrial respiration and NAD<sup>+</sup>/NADH balance in cells which complex I activity is compromised (<a href="#R1" rid="R1" class=" bibr popnode">Birsoy et al., 2014</a>; <a href="#R47" rid="R47" class=" bibr popnode">Santidrian et al., 2014</a>; <a href="#R59" rid="R59" class=" bibr popnode">Wheaton et al., 2014</a>; <a href="#R60" rid="R60" class=" bibr popnode">Yagi et al., 2006</a>). Expression of NDI1 in <em>Keap1</em> mutant cells rescued sensitivity to serine and asparagine deprivation (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 4j</a>). Like supplementation with DMG, expression of NDII also increase TCA cycle intermediates as well as elevate glutamate levels (<a href="#R34" rid="R34" class=" bibr popnode">Lozoya et al., 2018</a>;<a href="#R37" rid="R37" class=" bibr popnode">Martinez-Reyes et al., 2016</a>).</p><p id="P26" class="p p-last">While rescue of other aspects of cellular metabolism that are impaired in <em>Keap1</em> mutant cells can significantly improve their proliferative capacity in NEAA depleted conditions, we cannot exclude the possibility that this effect is also dependent on increases in intracellular glutamate levels. Here we provide strong evidence that cellular glutamate is predictive of sensitivity to NEAA deprivation. Genetic mutation of <em>Keap1</em>, small molecule activation of Nrf2, or treatment with the glutaminase inhibitor CB-839, which all reduce glutamate levels, result in sensitization of cancer cells to NEAA depletion. Conversely, modulating extracellular concentrations of glutamate, blocking glutamate efflux, increasing expression of glutamate transporters to promote uptake/re-uptake, or restoring other metabolic defects of <em>Keap1</em> mutant cells which also increase intracellular glutamate levels rescued exogenous NEAA dependency.</p></div><div id="S8" class="sec sec-last"><h3 id="S8title"><em>Keap1</em> mutant tumors require exogenous NEAAs <em>in vivo</em></h3><p id="P27" class="p p-first">Given the differential sensitivity of <em>Keap1</em> mutant and wildtype cells to exogenous serine or asparagine depletion <em>in vitro</em>, we assessed their dependency on these NEAAs <em>in vivo</em>. We utilized a diet lacking both serine and glycine (-SG) (<a href="#R35" rid="R35" class=" bibr popnode">Maddocks et al., 2013</a>; <a href="#R36" rid="R36" class=" bibr popnode">Maddocks et al., 2017</a>), a diet lacking asparagine, or treated mice with L-asparaginase (<a href="#R22" rid="R22" class=" bibr popnode">Gwinn et al., 2018</a>; <a href="#R26" rid="R26" class=" bibr popnode">Knott et al., 2018</a>). Mice were subcutaneously injected with either wildtype or <em>Keap1</em> mutant cells and upon tumor formation mice were randomized to different treatment groups. When depleting dietary serine and glycine, growth of <em>Keap1</em> mutant tumors was significantly attenuated compared to tumor growth on an amino acid control diet (AA CTL) (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5a</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 5a</a>). In contrast, we observed no effect on wildtype tumor growth in response to -SG diet (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5a</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 5a</a>). Similarly, treatment with L-asparaginase, or a diet lacking asparagine (-N) blunted growth of <em>Keap1</em> mutant but not wildtype tumors (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5b</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>c</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 5b</a>). To validate that the amino acid defined diets and L-asparaginase treatments reduced amino acid levels, we confirmed depletion of serine, glycine, and asparagine in plasma (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 5c</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">d</a>). In the case of asparagine, we observed that treatment with L-asparaginase is more effective in reducing circulating asparagine than the asparagine diet (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 5d</a>). This is likely because L-asparaginase is able to degrade free asparagine from the diet or asparagine produced by other cells while the asparagine deficient diet only eliminates dietary sources. When combining an asparagine free diet with L-asparaginase treatment we see that the asparagine free diet alone results in a moderate reduction in tumor growth, but L-asparaginase treatment alone or in combination with the asparagine diet strongly blunts the growth of <em>Keap1</em> mutant tumors (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5d</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>e</span></a>). These results are in line with the degree to which asparagine is reduced in the plasma (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 5d</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838573148304"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7004873_nihms-1545176-f0006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139838573148304"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC7004873/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>Keap1</em> mutant tumors require exogenous NEAAs <em>in vivo</em>.</strong><p id="P66"><strong>a)</strong> Relative tumor growth of subcutaneous tumors in animals receiving either -SG or AA CTL diet. <strong>b)</strong> Relative tumor growth of subcutaneous tumors in animals treated with either L-Asparaginase. <strong>c and d)</strong> Relative tumor growth of subcutaneous tumors in animals receiving -N or AA CTL diet in combination with L-asparaginase treatment. <strong>e and f)</strong> Relative tumor growth of subcutaneous <em>Keap1</em> mutant (e) or wildtype (f) tumors in animals receiving either -SG or AA CTL diet and either treated with CB-839 or vehicle. *p&#x0003c;0.05, **p&#x0003c;0.01, ****p&#x0003c;0.0001</p></div></div></div><p id="P28" class="p p-last">As NEAA limitation was synergistic with CB-839 treatment <em>in vitro</em> (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3i</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>j</span></a>), we next evaluated the impact of combining -SG diet with CB-839 treatment <em>in vivo</em> as administration of CB-839 reduces glutamate availability required for NEAA synthesis (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 6a</a>). As we have previously shown, <em>Keap1</em> mutant but not wildtype tumors are sensitive to treatment with CB-839 (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>)(<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5e</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>f</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 6b</a>). -SG diet along with CB-839 treatment further reduced <em>Keap1</em> mutant tumor growth in mice compared to either monotherapy. Surprisingly, wildtype tumors were extremely sensitive to combination therapy (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5f</span></a>). In line with what we have previously observed, -SG diet or CB-839 treatment alone had no effect on wildtype tumor growth. However, administration of CB-839 in combination with the -SG diet had a strong synergistic effect and significantly reduced wildtype tumor growth (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5f</span></a>). We characterized both wildtype and <em>Keap1</em> mutant tumors and stained for markers of Nrf2 activation (Nqo1), proliferation (phospho-Histone H3), oxidative damage (8-hydroxy-2&#x02019;-deoxyguanosine), and cell death (cleaved caspase3). In line with expectations, we see increased Nqo1 and decreased 8-hydroxy-2&#x02019;deoxyguanosine staining in Keap1 mutant tumors (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 6c</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">d</a>). Taken together, using both defined diets and enzymatic methods to deplete NEAAs, we demonstrate that <em>Keap1</em> mutant tumors have an increased dependency on exogenous NEAAs <em>in vivo</em>. Furthermore, using existing therapeutic strategies to decrease intracellular glutamate levels, we can suppress tumor growth by limiting exogenous NEAAs in <em>Keap1</em> WT tumors. These results provide novel therapeutic strategies for targeting <em>Kras</em> mutant NSCLC.</p></div></div><div id="S9" class="tsec sec"><h2 class="head no_bottom_margin" id="S9title">Discussion</h2><p id="P29" class="p p-first">Rewiring of cellular metabolism is a hallmark of cancer and is necessary to sustain chronic cellular proliferation (<a href="#R23" rid="R23" class=" bibr popnode">Hanahan and Weinberg, 2011</a>). The activation of oncogenes and loss of tumor suppressors directly regulates metabolism to support increased cell growth (<a href="#R24" rid="R24" class=" bibr popnode">Heiden and DeBerardinis, 2017</a>; <a href="#R56" rid="R56" class=" bibr popnode">Vander Heiden et al., 2009</a>). Although, much effort has been focused on understanding how changes to tumor cell metabolism can be leveraged for effective cancer therapies, there is a limited understanding of the metabolic differences between common genetic subtypes of cancer and how those can be targeted by rationale metabolic therapies. We have previously shown that Nrf2 activation by <em>Keap1</em> mutation results in the system x<sub>c</sub><sup>&#x02212;</sup> dependent export of glutamate, depleting intracellular glutamate levels (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>; <a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>) (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3b</span></a>, <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,c</span></span><span>c</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>f</span></a>). Based on our prior work we hypothesized that low intracellular glutamate in <em>Keap1</em> mutant tumors might impose a limitation for NEAA synthesis under conditions of nutrient stress. NEAAs are important building blocks for proteins, serve as signaling molecules (<a href="#R2" rid="R2" class=" bibr popnode">Briggs et al., 2016</a>; <a href="#R29" rid="R29" class=" bibr popnode">Larson et al., 2007</a>; <a href="#R42" rid="R42" class=" bibr popnode">Nicklin et al., 2009</a>; <a href="#R44" rid="R44" class=" bibr popnode">Rhoads et al., 1997</a>), generate essential co-factors and reducing molecules, and are substrates for other macromolecules (<a href="#R38" rid="R38" class=" bibr popnode">Mehrmohamadi and Locasale, 2015</a>). Targeting NEAA availability and synthesis in tumors is an attractive therapeutic strategy as highly proliferating tumor cells often require NEAAs in excess of what <em>de novo</em> synthesis can provide (<a href="#R10" rid="R10" class=" bibr popnode">DeNicola and Cantley, 2015</a>).</p><p id="P30">Here we demonstrate that limited glutamate availability reduces total pools of NEAAs (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1h</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 2</a>, <a href="/pmc/articles/PMC7004873/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>) and drives dependency of <em>Keap1</em> mutant cells on multiple NEAAs including serine, glycine, and asparagine (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>) in a system x<sub>c</sub><sup>&#x02212;</sup> -dependent manner. We observe that modulation of glutamate or cystine in the microenvironment can either enhance or restrict cancer cell growth in the context of NEAA depletion. We also show combined depletion of multiple NEAAs <em>in vitro</em> (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3i</span></a>&#x02013;<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>j</span></a>) and <em>in vivo</em> (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5e</span></a>) has a greater effect in reducing tumor growth in <em>Keap1</em> mutant tumors. Additionally, <em>Keap1</em> mutant cells uptake more NEAAs compared to wildtype cells both <em>in vitro</em> and <em>in vivo</em> and are sensitive to their depletion even as monotherapies (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1a</span></a>&#x02013;<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>d</span></a>).</p><p id="P31"><em>Keap1</em> mutant cells are able to synthesize both serine and asparagine in complete media and when they are depleted. In fact, rates of synthesis are similar to that of wildtype cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 2a</a> &#x00026; <a href="#SD1" rid="SD1" class=" supplementary-material">b</a>). However, <em>Keap1</em> mutant cells have an increased basal demand for serine (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1h</span></a>) and depletion of serine or asparagine results in a greater depletion in the total pools of these amino acids compared to wildtype cells (<a href="/pmc/articles/PMC7004873/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1h</span></a>). This suggests that when exogenous serine and asparagine are not available, <em>de novo</em> synthesis in <em>Keap1</em> mutant cells is not sufficient to keep up with cellular demand.</p><p id="P32">Activation of Nrf2 dramatically alters cellular metabolism and maintaining a large redox capacity is metabolically costl. <em>Keap1</em> mutant cells produce several times more GSH than wildtype cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3d</a>). Chronic production of GSH as well as other antioxidants greatly alters the availability and flux of many metabolites. The large pool of GSH can function as a metabolic sink for many important substrates including glutamate, glycine, cysteine and serine. This causes the diversion of these metabolites away from other biosynthetic pathways and generates multiple metabolic liabilities. While <em>Keap1</em> mutant cells are able to sustain high antioxidant capacity without compromising proliferation when nutrients are abundant, they are not able to sustain proliferation when particular metabolites are restricted (i.e. glutamine, serine, asparagine, glycine). The demand for serine is directly affected by production of GSH in <em>Keap1</em> mutant cells as it is a source of glycine and cysteine, and serine will be diverted to GSH production possibly at the expense of other biosynthetic reactions such as nucleotide synthesis and 1-carbon metabolism.</p><p id="P33">Nrf2-dependent metabolic rewiring also affects central carbon metabolism and results in defects in the TCA cycle with decreased glutamine incorporation and overall reduced abundance of TCA cycle intermediates (<a href="#R48" rid="R48" class=" bibr popnode">Sayin et al., 2017</a>). Decreased glutamate availability combined with reduced total abundance of aspartate likely limits the ability of <em>Keap1</em> mutant cells to synthesis sufficient amounts asparagine when it is depleted from the media.</p><p id="P34">In this study we observe that intracellular glutamate levels are a key factor dictating the ability of <em>Keap1</em> mutant cells to proliferate under NEAA deprivation. We use multiple approaches to increase intracellular glutamate levels and are able to rescue cellular proliferation in NEAA depletion (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>). Conversely, further depleting glutamate in <em>Keap1</em> mutant cells decreases cellular proliferation in conditions of mild NEAA restriction (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3i</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>j</span></a>) and further suppresses tumor growth (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5e</span></a>).</p><p id="P35">We show that reliance on exogenous NEAAs is a Nrf2-dependent phenotype (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure 2d</a>&#x02013;<a href="#SD1" rid="SD1" class=" supplementary-material">g</a>), as acute activation of Nrf2 is sufficient to sensitize <em>Keap1</em> wildtype cells to NEAA depletion in multiple contexts. While the pharmacokinetics of this particular Nrf2 activator prevent its efficient use <em>in vivo</em> (<a href="#R6" rid="R6" class=" bibr popnode">Cuadrado et al., 2019</a>; <a href="#R8" rid="R8" class=" bibr popnode">Davies et al., 2016</a>), strategies to increase ROS to elevate NRF2 activity are promising ways to sensitize wildtype cells to NEAA depletion (<a href="#R36" rid="R36" class=" bibr popnode">Maddocks et al., 2017</a>). Indeed, we are able to sensitize wildtype cells to serine and asparagine depletion by pre-treatment with oxidants (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2f</span></a>) which resulted in Nrf2 activation in wildtype cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3a</a>&#x02013;<a href="#SD1" rid="SD1" class=" supplementary-material">c</a>). This suggests that modulation of NEAA availability is widely applicable to both <em>Keap1</em> mutant and wildtype tumors where treatment with oxidizing agents sensitizes low antioxidant tumors to depletion of NEAAs.</p><p id="P36">Furthermore, activation of Nrf2 in pancreatic cancer cells, is sufficient to sensitize cells to NEAA deprivation (<a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2c</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>d</span></a>) indicating that activation of the endogenous antioxidant response via Nrf2 stabilization results in a similar metabolic phenotype regardless of tissue of origin. Furthermore, guided by insights from resistance mechanisms (<a href="/pmc/articles/PMC7004873/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>), we demonstrate that the metabolic dependency on NEAAs we uncover in high antioxidant tumors can be exploited in a more general fashion in low antioxidant tumors that lack alterations in the Keap1/Nrf2 antioxidant pathway. We show that cancers, such as <em>Kras</em> and <em>p53</em> mutant tumors that do not respond to known metabolic therapies (e.g. glutaminase inhibition or L-Asparaginase), can be targeted by combination therapy. We observe that by pharmacological depletion of intracellular glutamate levels (CB-839) we strongly sensitize <em>Keap1</em> wildtype tumors to dietary restriction of serine and glycine (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5f</span></a>), similar to what is observed in <em>Keap1</em> mutant tumors (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5e</span></a>) with no toxicity. The combination of glutaminase inhibition with dietary restriction of serine and glycine did not alter Nrf2 pathway activation in wildtype tumors (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 6c</a>). Instead, by using CB-839 to reduce glutamate in wildtype tumors we are able to mimic the metabolic environment of <em>Keap1</em> mutant tumors and induce sensitivity to NEAA depletion. This further strengthens our observations that intracellular glutamate levels dictates dependency on exogenous NEAAs.</p><p id="P37">Our data highlights the importance of understanding how particular mutations, other than the well-known drivers (eg. <em>Kras, p53</em>), can strongly impact the metabolic landscape of tumors and their response to metabolic therapies. For example, elegant work has shown that <em>Kras</em> and <em>p53</em> status are important in regulating serine metabolism and cell survival during serine deprivation (<a href="#R35" rid="R35" class=" bibr popnode">Maddocks et al., 2013</a>; <a href="#R36" rid="R36" class=" bibr popnode">Maddocks et al., 2017</a>). However, the effect of <em>Keap1</em> mutations on glutamate availability for NEAA synthesis &#x0201c;overrides&#x0201d; the effects of oncogenic <em>KRAS</em> or <em>p53</em> mutation on serine and glycine deprivation. These observations further emphasize the need for more comprehensive metabolic characterization of various genotypic subtypes of cancer.</p><p id="P38" class="p p-last">In Summary, we uncover a general mechanism in which a specific genotype, renders cells dependent on multiple NEAAs including serine, glycine, and asparagine. This dependency on exogenous NEAAs can be therapeutically targeted by dietary or enzymatic depletion of specific amino acids to blunt tumor growth (<a href="/pmc/articles/PMC7004873/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6</span></a>) and is broadly applicable regardless of tissue of origin. Additionally, utilizing oxidizing agents or a small molecule glutaminase inhibitor to modulate cellular metabolism, we strongly sensitize Keap1 wild type cells to deprivation of NEAAs (<a href="/pmc/articles/PMC7004873/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Figure 6b</span></a>, <a href="/pmc/articles/PMC7004873/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2f</span></a> &#x00026; <a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5f</span></a>). Using our pre-clinical models, we are the first to show that dietary restriction or enzymatic depletion of asparagine can lead suppression of <em>Keap1</em> mutant tumor growth (<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5b</span></a>&#x02013;<a href="/pmc/articles/PMC7004873/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>d</span></a>). Importantly, we repurpose a well-established metabolic therapy currently used for Acute Lymphoblastic Leukemia, L-Asparaginase, for the treatment of <em>Keap1</em> mutant lung cancer. Our work, as well as that of others, support that metabolite restriction through pharmacological or dietary means can effectively suppress tumor growth (<a href="#R16" rid="R16" class=" bibr popnode">Elia et al., 2017</a>; <a href="#R19" rid="R19" class=" bibr popnode">Gao et al., 2019</a>; <a href="#R22" rid="R22" class=" bibr popnode">Gwinn et al., 2018</a>; <a href="#R25" rid="R25" class=" bibr popnode">Hopkins et al., 2018</a>; <a href="#R26" rid="R26" class=" bibr popnode">Knott et al., 2018</a>; <a href="#R33" rid="R33" class=" bibr popnode">Loayza-Puch et al., 2016</a>; <a href="#R35" rid="R35" class=" bibr popnode">Maddocks et al., 2013</a>; <a href="#R36" rid="R36" class=" bibr popnode">Maddocks et al., 2017</a>; <a href="#R50" rid="R50" class=" bibr popnode">Sousa et al., 2016</a>; <a href="#R52" rid="R52" class=" bibr popnode">Sullivan et al., 2018</a>). Moving forward, combination of dietary modification with standard of care chemotherapeutics may improve patient response. Additionally, based on our findings, modulation of intracellular glutamate levels through pharmacological intervention may be used to sensitize KRAS driven NSCLC to NEAA depletion, independent of <em>Keap1</em> status and may be a broadly applicable therapeutic strategy in other cancer subtypes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC7004873/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139838573143456"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7004873_nihms-1545176-f0007.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-1545176-f0007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC7004873/bin/nihms-1545176-f0007.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139838573143456"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC7004873/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6:</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Activation of oxidative stress response depletes intracellular glutamate and generates a dependency on exogenous amino acids</strong><p id="P67"><strong>a)</strong> Schematic depicting how activation of the oxidative stress response via genetic, pharmacologic or physiological ROS stress to stabilize Nrf2, depletes intracellular glutamate. In cells with activated Nrf2 glutamate is shuttled into glutathione (GSH) biosynthesis or exported through the system x<sub>c</sub><sup>&#x02212;</sup> antiporter (xCT) to import cystine. This depletes intracellular glutamate levels and limits its availability for other biosynthetic reactions. Reduced availability of intracellular glutamate restricts its use in transamination reactions for synthesis of nonessential amino acids (NEAA) rendering cells dependent on uptake of NEAAs from the microenvironment.</p></div></div></div></div><div id="S10" class="tsec sec"><h2 class="head no_bottom_margin" id="S10title">Limitations</h2><p id="P39" class="p p-first-last">While we provide evidence that these findings are applicable to cancers from other tissues of origin, we did not exhaustively test multiple subtypes and in some cases <em>Keap1</em> mutation may not drive NEAA dependency in specific tissues. Additionally, we showed that our findings regarding serine deprivation were also true in human cell lines. However, the mutational complexity in human cancers is much greater compared to murine cancer models. Thus directly translating all of our findings to human models and patients may be difficult without further investigation.</p></div><div id="S11" class="tsec sec"><h2 class="head no_bottom_margin" id="S11title">STAR METHODS</h2><div id="S12" class="sec sec-first"><h3 id="S12title">Lead Contact and Materials Availability</h3><p id="P40" class="p p-first-last">Further information and requests for resources and reagents should be directed to Lead Contact, Thales Papagiannakopoulos (<a href="mailto:dev@null" data-email="gro.enognaluyn@10tgapap" class="oemail">gro.enognaluyn@10tgapap</a>) This study did not generate new unique reagents.</p></div><div id="S13" class="sec"><h3 id="S13title">Experimental Model and Subject Details</h3><div id="S14" class="sec sec-first"><p></p><h4 id="S14title" class="inline">Mice </h4><p id="P41" class="p p-first-last">All animal studies described were approved by the NYU Langone Medical Center Institutional Animal Care and Use Committee. Animals were housed according to IACUC guidelines in ventilated caging in a specific pathogen free (SPF) animal facility. 5 &#x000d7; 10<sup>5</sup> cells were implanted subcutaneously into C57BL/6J female littermates approximately 6&#x02013;8 weeks in age. Tumor volume was measured by caliper and volume was calculated (Length &#x000d7; Width<sup>2</sup> &#x000d7; 0.5). After tumor establishment phase (tumor volume ~50&#x02013;100mm<sup>3</sup>), animals were randomized and assigned to a treatment group. Animals either received an amino acid control diet, diet lacking both serine and glycine, or a diet lacking asparagine (Envigo), 200mg/kg CB-839 or vehicle (Calithera) twice daily administered through oral gavage as previously described (<a href="#R7" rid="R7" class=" bibr popnode">Davidson et al., 2016</a>), 60U of L-Asparaginase (Abcam) or vehicle once daily administered through intraperitoneal injection as before (<a href="#R26" rid="R26" class=" bibr popnode">Knott et al., 2018</a>) or some treatment combination as indicated. No animals were excluded from analysis. Tumor growth was tracked for a minimum of 8 tumors per experimental group.</p></div><div id="S15" class="sec sec-last"><p></p><h4 id="S15title" class="inline">Cell lines and culture </h4><p id="P42" class="p p-first-last">Murine Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup> wildtype and <em>Keap1</em> mutant isogenic clonal cell lines and LKR10/13 cell lines were previously established (<a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a>). Additional KP parental cell lines were previously established and described (<a href="#R14" rid="R14" class=" bibr popnode">Dimitrova et al., 2016</a>). Murine Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup> pancreatic cancer cell lines were provided by the Kimmelman lab. Murine cell lines were originally derived from female mice. Human cell lines were acquired from ATCC. All cell lines tested negative for mycoplasma (PlasmoTest, InvivoGen). All cell lines were cultured in a humidified incubator at 37&#x000b0;C and 5% CO<sub>2</sub>. Cells were maintained in either DMEM or RPMI-1640 (Cellgro) supplemented with 10% fetal bovine serum (Sigma Aldrich) and gentamicin (Invitrogen).</p></div></div><div id="S16" class="sec"><h3 id="S16title">Method Details</h3><div id="S17" class="sec sec-first"><p></p><h4 id="S17title" class="inline">Cell proliferation and viability assays </h4><p id="P43" class="p p-first">For cell proliferation assays conducted under different drug or media conditions as indicated, cells growing in DMEM were trypsinized, counted and plated into 12 well plate dishes (BD/Falcon) in 1mL of RPMI media. For rescue experiments, cells were treated with indicated drugs after attachment, 500nM Erastin (EMD Millipore), 6mM Glutamate (Sigma Aldrich), 50uM Trolox (Acros Organics), 0.5mM <em>N</em>-acetyl-L-cysteine (NAC, Acros Organics), 30uM hypoxanthine (Acros Organics), 3mM formate (Amresco), 16uM thymidine (Sigma Aldrich), 2mM dimethyl-ketoglutarate (Sigma Aldrich) or 1uM KI-696 (Nrf2 activator; provided by Craig Thomas, NCI). In experiments where the Nrf2 activator (KI696) was used, cells were pretreated with 1uM for 3 days prior to the start of the experiment. For deprivation experiments, cells were washed with PBS and media was replaced with 1mL of complete RPMI or RPMI lacking indicated amino acid and supplemented with 10% dialyzed FBS and cells were re-treated with indicated drugs. RPMI was prepared from a powder mix without amino acids (US Biological)according to manufacturer&#x02019;s instructions. All other amino acids besides those indicated were added to the RPMI mixture in the same concentrations present in RPMI-1640 formulation (Cellgro, Corning). For oxidant treatment experiments cells were pre-treated for 48 hours with 10uM or 50uM buthionine sulfoximine (BO, Sigma Aldrich), 5uM dimethyl-fumarate (DMF, Sigma Adrich), or 0.5uM auronafin (Sigma Aldrich) unless otherwise indicated. Proliferation experiments were carried out for 5 days post drug treatment and collected by staining. Cells were stained with a 0.5% crystal violet (Fisher) solution in 20% methanol. Plates were then washed, dried, and crystal violet was eluted in 400uL of 10% acetic acid.</p><p id="P44">For cell viability assays cells were plated in a white, opaque 96-well plate with clear bottom at a density of 1000 cells/well in RPMI or RPMI with modified amino acid content. After attachment, CB-839 (Selleck) or L-Asparaginase (AbCam) were added at the indicated concentrations. After 3 days, cell viability in the presence of all compounds was assessed by cell titer glo (Promega).</p><p id="P45" class="p p-last">All data is represented as relative to vehicle treated condition in complete media unless otherwise indicated.</p></div><div id="S18" class="sec"><p></p><h4 id="S18title" class="inline">qPCR analysis </h4><p id="P47" class="p p-first-last">mRNA was harvested from cells using an RNeasy mini kit (Qiagen) according to manufacturer&#x02019;s protocol. Extracted mRNA was used to synthesize cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosciences, ThermoFisher Scientific) according to manufacturer&#x02019;s protocol. Gene expression was analyzed by quantitative reverse transcription polymerase chain reaction on a QuantStudio3 (Applied Biosciences, ThermoFisher Scientific). A List of specific primers used can be found in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1.</a></p></div><div id="S19" class="sec"><p></p><h4 id="S19title" class="inline">Immunoblotting </h4><p id="P48" class="p p-first-last">Cells were collected and lysed in 150uL of ice-cold RIPA buffer (ThermoFisher Scientific) supplemented with 1X protease and phosphatase inhibitor (ThermoFisher Scientific) and mixed on a rotator at 4&#x000b0;C for 30 minutes. Supernatant was collected after centrifugation at 15,000rpm for 15 minutes. Protein concentrations were determined using the Bio-Rad DC Protein Assay.20 &#x02013; 40&#x003bc;g of total protein was separated on a 4&#x02013;12% Bis-Tris gradient gel (Invitrogen) and then transferred onto nitrocellulose membrane (BioRad). A custom made Nrf2 antibody (1:1000, provided by Edward Schmidt, Montana State University) and anti-HSP90 (1:4000, BD #610418) antibody were used. Nrf2 was detected by a goat anti-rabbit secondary antibody (1:25000, LI-COR Biosciences). HSP90 was detected by a goat anit-mouse secondary antibody (1:25000, LI-COR Biosciences).</p></div><div id="S20" class="sec"><p></p><h4 id="S20title" class="inline">Immunohistochemistry </h4><p id="P49" class="p p-first-last">Mice were euthanized by carbon dioxide asphyxiation. Tumors were dissected and fixed with 10% formalin overnight, transferred to 70% ethanol, and then embedded in paraffin. 3&#x003bc;M thick sections were cut and stained with H&#x00026;E. Immunohistochemistry on paraffin-embeded sections was performed using antibodies against Nqo1 (1:100, Sigma, HPA007308), phospho-histone-H3 (1:100, Ser10; Cell Signaling, #9701), 8-oxo-deoxyguanosine (1:100, Abcam, #ab48508), and cleaved caspase3 (1:200, Cell Signalin, #9579). Chromogenic IHC was performed on a Leica Bond RX and stained slides were imaged on a Leica SCN400 F whole-slide scanner. For Nqo1, 8-oxo-deoxyguanosine, and phospho-histone-H3 staining antigen retrieval was performed using antigen retrieval buffer pH6 (Leica) for 20 min and for cleaved caspase3 staining, antigen retrieval buffer pH9 (Leica) was used for 20min. For detection, Leica Bond Polymer Refine Detection secondary antibody (Leica, #DS9800) was used according to manufacturer&#x02019;s protocol for Nqo1, phosphor-histone-H3 and cleaved caspase3. 8-oxo-deoxyguanosine was detected with the Biocare MM HRP-polymer secondary antibody (Biocare, #MM620H) according to manufacturer&#x02019;s protocol.</p></div><div id="S21" class="sec"><p></p><h4 id="S21title" class="inline">Cell Line generation (Keap1 complement cells, SLC1A3 overexpression and PSAT knockouts) </h4><p id="P50" class="p p-first">Keap1 complemented cells were generated by cloning mouse Keap1 cDNA into Gibson compatible lentiviral backbone with a hygromycin resistance cassette. Cells over expressing SLC1a3 were generated by cloning human SLC1a3 into the PMXS-puro retoviral backbone. sgPsat or sgCtl cells were generated by cloning sgRNA sequences into the LentiV2 Puro backbone (See <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>).</p><p id="P51" class="p p-last">Lentiviruses or retroviruses were then produced by co-transfection of HEK293 cells with lentiviral or retroviral backbone constructs and packaging vectors (delta8.2 and VSV-G) using PEI Pro (PolyPlus). Viral supernatant was collected 48 hours and 72 hours after transfection. Recipient cells were incubated with viral supernatant for 24 hours after each collection. Cells were then selected with either puromycin or hygromycin.</p></div><div id="S22" class="sec"><p></p><h4 id="S22title" class="inline">GC/MS analysis of polar metabolites and stable isotope tracing </h4><p id="P52" class="p p-first">For analysis of cells, 1 &#x000d7; 10<sup>5</sup> cells were seeded in 1mL of RPMI-1640 in 12 well plates. Where indicated, cells were pretreated with 6mM glutamate, 500nM Erastin, or 1uM KI696. Media was then replaced with fresh RPMI lacking serine or asparagine where indicated and supplement with 10% dialyzed FBS. For tracing experiments media contained 11mM [U<sup>13</sup>C]-D-glucose, 2mM [U<sup>13</sup> C]-L-glutamine, 2mM [&#x003b1;<sup>15</sup>N]-L-glutamine, or 285&#x003bc;M [U<sup>13</sup> C]-L-serine (Cambridge Isotope Laboratory). Cells were treated with 250nM CB-839 and cultured for 1&#x02013;3hours. Cells were washed 2X in ice cold saline and then collected by scraping in 250uL of 80% (v/v) of ice-cold methanol containing 1.4ug/mL norvaline (Sigma Aldrich). Samples were vortexed for 10min at 4&#x000b0;C and then centrifuged at max speed for 5 minutes. Supernatant was transferred to fresh tubes and then dried in a speed vac. For analysis of mouse plasma, whole blood was collected at the time of sacrifice by a retro-orbital bleed with heparin coated capillary tubes (Fisher) into EDTA containing microcentrifuge tubes. Whole blood was centrifuged for 5 minutes at 1600g. Cleared plasma was transferred to fresh tubes and 4uL of plasma was then aliquoted and used for analysis. 80% (v/v) methanol containing 1.4ug/mL norvaline was added to plasma and samples were then dried in a speed vac. Dried metabolite extracts were then derivatized with 20uL O-methoxyamine-hydrochloride (MOX) reagent (Sigma) in pyridine (Sigma Aldrich) at a concentration of 20mg/mL for 60min at 37&#x000b0;C and 30uL of <em>N-</em>tert-butyldimethylsilyl-N-Methyltrifluoracetamide with 1% <em>tert</em>-Butyldimethylchlorosilane (TBDMS, Sigma) for 30min at 37&#x000b0;C. After derivatization, samples were analyzed by GC-MS using an HP-5MS column (Agilent Technologies) in an Agilent Intuvo gas chromatograph coupled to an Agilent 5997B mass spectrometer. Helium was used as the carrier gas at a flow rate of 1.2mL/minute. One microliter of sample was injected in split mode (split 1:1) at 270&#x000b0;C. After injection the GC oven was held at 100&#x000b0;C for one minute and then increased to 300&#x000b0;C at 3.5&#x000b0;C /min. The oven was then ramped to 320&#x000b0;C at 20&#x000b0;C /min and held for 5min at 320&#x000b0;C.</p><p id="P53" class="p p-last">The MS system operated under electron impact ionization at 70 eV and the MS source and quadrupole were held at 230&#x000b0;C and 150&#x000b0;C respectively the detector was used in scanning mode, and the scanned ion range was 10&#x02013;650 <em>m/z</em>. Mass isotopomer distributions were determined by integrating the appropriate ion fragments for each metabolite (<a href="#R31" rid="R31" class=" bibr popnode">Lewis et al., 2014</a>) using MATLAB (Mathworks) and an algorithm adapted from Fernandez and colleagues (<a href="#R17" rid="R17" class=" bibr popnode">Fernandez et al., 1996</a>) that corrects for natural abundance. For all data total or relative metabolite pool sizes are normalized to cell counts for each condition.</p></div><div id="S23" class="sec sec-last"><p></p><h4 id="S23title" class="inline">LC/MS analysis of glutathione and stable isotope tracing </h4><p id="P54" class="p p-first-last">Metabolites were extracted in the same way as for GC/MS analysis. Once dried, metabolite extracts were resuspended with 200&#x003bc;L of &#x02212;20&#x000b0;C 40:40:20 methanol:acetonitrile:water with 0.5% formic acid, vortexed, and held on ice for 10 min. NH<sub>4</sub>HCO<sub>3</sub> (15%(w/v)) was added and samples were vortexed and held on ice 20 minutes before centrifugation 2 times at 4&#x000b0;C at 21,130 &#x000d7; g for 30 minutes each. Metabolite levels in samples were measured using a quadrupole-orbitrap mass spectrometer (Q Exactive, Thermo Fisher Scientific, San Jose, CA) operating in negative ion mode was coupled to hydrophilic interaction chromatography via electrospray ionization and used to scan from m/z 70 to 1000 at 1 Hz and 75,000 mass resolution. LC separation was on a XBridge BEH Amide column (2.1 mm &#x000d7; 150 mm, 2.5 m particle size, 130 &#x000c5; pore size; Waters, Milford, MA) using a gradient of solvent A (20 mM ammonium acetate, 20 mM ammonium hydroxide in 95:5 water: acetonitrile, pH 9.45) and solvent B (acetonitrile). Flow rate was 150 &#x003bc;L/min. The LC gradient was: 0&#x02009;min, 90% B; 2&#x02009;min, 90% B; 3&#x02009;min, 75% B; 7&#x02009;min, 75% B; 8&#x02009;min, 70% B; 9&#x02009;min, 70% B; 10&#x02009;min, 50% B; 12min, 50% B; 13&#x02009;min, 25% B; 14&#x02009;min, 25% B; 16&#x02009;min, 0% B; 20.5&#x02009;min, 0% B; 21&#x02009;min, 90% B; 25&#x02009;min, 90% B. 10ul of sample was injected into the instrument.</p></div></div><div id="S24" class="sec"><h3 id="S24title">Quantification and Statistical Analysis</h3><p id="P55" class="p p-first-last">Values are presented as mean &#x000b1; SEM. For statistical analysis we used Graphpad Prism software v 8.1.2 (Graphpad): two-way ANOVA for tumor growth and 2-sided Student&#x02019;s t-test for cell proliferation, metabolite analysis, and gene expression analysis. All experiments were repeated at least twice. All cell proliferation experiments and metabolite analysis contained 3 biological replicates. Cell viability assays contained 8 biological replicates and animal experiments and materials generated and analyzed from animal experiments contained a minimum of 5 biological replicates with a maximum of 10.</p></div><div id="S25" class="sec sec-last"><h3 id="S25title">Data and Code Availability</h3><p id="P56" class="p p-first-last">This study did not generate any unique datasets or code.</p></div></div><div id="unreferenced-ft" class="tsec sec"><div class="unreferenced">​
                    <!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><!--caption a7--><div class="caption"><!--caption a8--><strong>KEY RESOURCES TABLE</strong></div><div class="xtable"><table frame="box" rules="all" class="rendered small default_table"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">REAGENT or RESOURCE</th><th align="left" valign="middle" rowspan="1" colspan="1">SOURCE</th><th align="left" valign="middle" rowspan="1" colspan="1">IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Antibodies</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nrf2 (1:1000)</td><td align="left" valign="top" rowspan="1" colspan="1">Edward Schmidt&#x02019;s Lab</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hsp90 (1:4000)</td><td align="left" valign="top" rowspan="1" colspan="1">BD Biosciences</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#610418; RRID:AB_397798</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nqo1 (1:100)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# HPA007308; RRID:AB_1079501</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cleaved Caspase3 (1:200)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 9579, RRID:AB_10897512</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Phosph-histone-H3 (1:100)</td><td align="left" valign="top" rowspan="1" colspan="1">Cell Signaling</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#9701; RRID:AB_331535</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8-oxo-deoxyguanosine (1:100)</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat#ab48508; RRID:AB_867461</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Chemicals, Peptides, and Recombinant Proteins</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glutamate (6mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# G8415</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Erastin (500nM)</td><td align="left" valign="top" rowspan="1" colspan="1">EMD Millipore</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 329600</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CB-839 (250nM)</td><td align="left" valign="top" rowspan="1" colspan="1">Selleck Chem</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# S7655</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trolox (50&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Acros Organics</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# AC218940010</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><em>N</em>-acetyl-L-cysteine (0.5mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Acros Organics</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 160280250</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypoxanthine (20&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Acros Organics</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 122010250</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Formate (3mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Amresco</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# K975</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Thymidine (16&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# T1895</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KI696 (1&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Craig Thomas&#x02019;s Lab</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buthionine sulfoximine (50/100&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# B2515</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dimethyl-fumarate (5&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 242926</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dimethyl-ketoglutarate (2mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 349631</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Auronafin (0.5&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# A6733</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">L-Asparaginase</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# ab73439</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PEI Pro</td><td align="left" valign="top" rowspan="1" colspan="1">Poly Plus</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 71002-812</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Puromycin (3ug/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Fisher Scientific</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# AAJ61278ME</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hygromycin</td><td align="left" valign="top" rowspan="1" colspan="1">Corning</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 30-240-CR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">[UC<sup>13</sup>]-D-glucose (11mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Cambridge Isotope Laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CLM-1396</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">[UC<sup>13</sup>]-L-glutamine (2mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Cambridge Isotope Laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CLM-1822</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">[UC<sup>13</sup>]-L-serine (285&#x003bc;M)</td><td align="left" valign="top" rowspan="1" colspan="1">Cambridge Isotope Laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CLM-1574</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">[&#x003b1;<sup>15</sup>N]-L-glutamine (2mM)</td><td align="left" valign="top" rowspan="1" colspan="1">Cambridge Isotope Laboratories</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# NLM-1016</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Norvaline (1.4ug/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# N7627</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O-Methoxyamine hydrochloride (20mg/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 33045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pyridine</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 270407</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><em>N-</em>tert-butyldimethylsilyl-N-Methyltrifluoracetamide with 1% <em>tert</em>-Butyldimethylchlorosilane</td><td align="left" valign="top" rowspan="1" colspan="1">Sigma Aldrich</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 375934</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RPMI without glucose &#x00026; amino acids</td><td align="left" valign="top" rowspan="1" colspan="1">US Biologicals</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# R9010-01</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Critical Commercial Assays</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RNeasy mini Kit</td><td align="left" valign="top" rowspan="1" colspan="1">Qiagen</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 74106</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell titer Glo</td><td align="left" valign="top" rowspan="1" colspan="1">Promega</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# G7572</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">High Capacity cDNA Reverse Transcription Kit</td><td align="left" valign="top" rowspan="1" colspan="1">Applied Biosciences</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# 4374967</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Experimental Models: Cell Lines</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup>;Keap1<sup>+/+</sup> murine lung adenocarcinoma</td><td align="left" valign="top" rowspan="1" colspan="1">Papagiannakopoulos Laboratory</td><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup>;Keap1<sup>&#x02212;/&#x02212;</sup> murine lung adenocarcinoma</td><td align="left" valign="top" rowspan="1" colspan="1">Papagiannakopoulos Laboratory</td><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup> murine lung adenocarcinoma (multiple lines)</td><td align="left" valign="top" rowspan="1" colspan="1">Papagiannakopoulos Laboratory</td><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R14" rid="R14" class=" bibr popnode">Dimitrova et al., 2016</a></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LKR10/13 (Kras<sup>G12D/+</sup>;p53<sup>+/+</sup>;Keap1<sup>+/+</sup> or Keap1<sup>&#x02212;/&#x02212;</sup>), murine lung adenocardinoma</td><td align="left" valign="top" rowspan="1" colspan="1">Papagiannakopoulos Laboratory</td><td align="left" valign="top" rowspan="1" colspan="1"><a href="#R46" rid="R46" class=" bibr popnode">Romero et al., 2017</a></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kras<sup>G12D/+</sup>;p53<sup>&#x02212;/&#x02212;</sup> murine pancreatic ductal adenocarcinoma (multiple lines)</td><td align="left" valign="top" rowspan="1" colspan="1">Kimmelman Laboratory</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H1299</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5803, RRID:CVCL_0060</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H358</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5807, RRID:CVCL_1559</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H1563</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5875, RRID:CVCL_1475</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H2073</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5918, RRID:CVCL_1521</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H1975</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5908, RRID:CVCL_1511</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H1573</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5877, RRID:CVCL_1478</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H1944</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5907, RRID:CVCL_1508</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H2122</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5985, RRID:CVCL_1531</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-7909, RRID:CVCL_0023</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H1355</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5865, RRID:CVCL_1464</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H23</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5800, RRID:CVCL_1547</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">H2030</td><td align="left" valign="top" rowspan="1" colspan="1">ATCC</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# CRL-5914, RRID:CVCL_1517</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Experimental Models: Organisms/Strains</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6J</td><td align="left" valign="top" rowspan="1" colspan="1">Jackson Laboratory</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# JAX:000664, RRID:IMSR_JAX:000664</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Oligonucleotides</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Full list of oligos</td><td align="left" valign="top" rowspan="1" colspan="1">See <a href="#SD1" rid="SD1" class=" supplementary-material">Table S1</a></td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><strong>Other</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amino Acid Control Diet</td><td align="left" valign="top" rowspan="1" colspan="1">Envigo</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# TD.110839</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">-Serine and Glycine Diet</td><td align="left" valign="top" rowspan="1" colspan="1">Envigo</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# TD.160752</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">-Asparagine Diet</td><td align="left" valign="top" rowspan="1" colspan="1">Envigo</td><td align="left" valign="top" rowspan="1" colspan="1">Cat# TD.180520</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139838573141152"><a target="object" rel="noopener" href="/pmc/articles/PMC7004873/table/T1/?report=objectonly">Open in a separate window</a></div></div><div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="caption-a.o.h.atitle">Highlights</h3></div><ul class="unordered" style="list-style-type:disc" id="L2"><li><div id="P68"><em>Keap1</em> mutations drive non-essential amino acid (NEAA) dependency in cancer</div></li><li><div id="P69">Intracellular glutamate levels dictate cellular ability to survive NEAA deprivation</div></li><li><div id="P70">Restriction of NEAA can suppress <em>Keap1</em> mutant tumor growth <em>in vivo</em></div></li><li><div id="P71">Limiting glutamate by glutaminase inhibition enhances response to NEAA deprivation</div></li></ul></div><div class="boxed-text-box whole_rhythm hide-overflow" id="BX2"><div class="caption"><h3 id="caption-a.o.i.atitle">Context and Significance</h3></div><p id="P72">Cancer cells show changes in metabolism that a lot of the current research is trying to exploit for anti-cancer therapies. However, we still understand little about the metabolic differences between common genetic subtypes of cancer. Researchers at the NYU School of Medicine have uncovered a general mechanism by which cancer cells with chronic activation of the antioxidant response become dependent on non-essential amino acids (NEAAs), independently of their tissue of origin, due to low levels of the metabolite glutamate. By restricting NEAA availability, the authors are able to suppress tumor growth in mouse models. These findings reveal a mechanism for NEAA dependency that is applicable to different types of cancers and can also be extended to cancers with low antioxidant response by limiting glutamate availability.</p></div></div></div><div id="SM1" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="SM1title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>2</h4><div class="sup-box half_rhythm" id="d36e1846"><a href="/pmc/articles/PMC7004873/bin/NIHMS1545176-supplement-2.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(78M, pdf)</sup></div></div></div><div id="S26" class="tsec sec"><h2 class="head no_bottom_margin" id="S26title">Acknowledgements</h2><div class="sec"><p id="P57">We would like to thank Karen Vousden, Richard Possemato, and Michael Pacold for feedback regarding serine metabolism and dietary experiments, Kivanc Birsoy for providing the Slc1a3 cDNA constructs and Seth Parker for help with GC-MS methods and data analysis. We would like to thank Calithera Biosciences for providing CB-839 for <em>in vivo</em> use, Alec Kimmelman for providing the murine pancreatic cancer cell line and Doug Biancur for technical assistance. We would like to thank Craig Thomas (NCI) for providing KI696 and Paul Oberstein for providing L-Asparaginase. T.P. is supported by the National Institute of Health (1K22 CA201088-01; 1R37CA222504-01A1;1R01CA227649-01) and American Cancer Society Research Scholar Grant (RSG-17-200-01 - TBE). S.E.L. was supported by an NIH training grant (5T32HL007151-38). W.L.W is supported by an NIH training grant (T32GM007308). V.I.S. received support from the Swedish Society for Medical Research. We thank the NYU Langone Medical Center Cores and the Animal Resources Facility staff for their support of the animal studies.</p><p id="P58">Declarations of interests</p><p id="P59">T.P. Reports grants and consulting fees outside of the submitted work from Dracen Pharmaceuticals, Agios, Bristol Meyers Squib, and Calithera Biosciences.</p></div></div><div id="fn-group-a.n.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.n.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN3"><p id="P60" class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></p></div></div><div id="ref-list-a.n.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.n.ctitle">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R1"><span class="mixed-citation">Birsoy K, Possemato R, Lorbeer FK, Bayraktar EC, Thiru P, Yucel B, Wang T, Chen WW, Clish CB, and Sabatini DM (2014). <span class="ref-title">Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">508</span>, 108&#x02013;112. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4012432/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24670634" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Metabolic+determinants+of+cancer+cell+sensitivity+to+glucose+limitation+and+biguanides&amp;author=K+Birsoy&amp;author=R+Possemato&amp;author=FK+Lorbeer&amp;author=EC+Bayraktar&amp;author=P+Thiru&amp;volume=508&amp;publication_year=2014&amp;pages=108-112&amp;pmid=24670634&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R2"><span class="mixed-citation">Briggs KJ, Koivunen P, Cao S, Backus KM, Olenchock BA, Patel H, Zhang Q, Signoretti S, Gerfen GJ, Richardson AL, et al. (2016). <span class="ref-title">Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">166</span>, 126&#x02013;139. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4930557/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27368101" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Paracrine+Induction+of+HIF+by+Glutamate+in+Breast+Cancer:+EglN1+Senses+Cysteine&amp;author=KJ+Briggs&amp;author=P+Koivunen&amp;author=S+Cao&amp;author=KM+Backus&amp;author=BA+Olenchock&amp;volume=166&amp;publication_year=2016&amp;pages=126-139&amp;pmid=27368101&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R3"><span class="mixed-citation">Cancer Genome Atlas Research, N. (2012). <span class="ref-title">Comprehensive genomic characterization of squamous cell lung cancers</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">489</span>, 519&#x02013;525. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3466113/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22960745" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive+genomic+characterization+of+squamous+cell+lung+cancers&amp;volume=489&amp;publication_year=2012&amp;pages=519-525&amp;pmid=22960745&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R4"><span class="mixed-citation">Cancer Genome Atlas Research, N. (2014). <span class="ref-title">Comprehensive molecular profiling of lung adenocarcinoma</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">511</span>, 543&#x02013;550. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4231481/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25079552" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive+molecular+profiling+of+lung+adenocarcinoma&amp;volume=511&amp;publication_year=2014&amp;pages=543-550&amp;pmid=25079552&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R5"><span class="mixed-citation">Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, et al. (2018). <span class="ref-title">Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics</span>. <span class="ref-journal">Cancer</span>
<span class="ref-vol">124</span>, 2785&#x02013;2800. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6033186/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29786848" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Annual+Report+to+the+Nation+on+the+Status+of+Cancer,+part+I:+National+cancer+statistics&amp;author=KA+Cronin&amp;author=AJ+Lake&amp;author=S+Scott&amp;author=RL+Sherman&amp;author=AM+Noone&amp;volume=124&amp;publication_year=2018&amp;pages=2785-2800&amp;pmid=29786848&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R6"><span class="mixed-citation">Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, Attucks OC, Franklin S, Levonen AL, Kensler TW, et al. (2019). <span class="ref-title">Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases</span>. <span class="ref-journal">Nat Rev Drug Discov</span>
<span class="ref-vol">18</span>, 295&#x02013;317. [<a href="https://pubmed.ncbi.nlm.nih.gov/30610225" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Therapeutic+targeting+of+the+NRF2+and+KEAP1+partnership+in+chronic+diseases&amp;author=A+Cuadrado&amp;author=AI+Rojo&amp;author=G+Wells&amp;author=JD+Hayes&amp;author=SP+Cousin&amp;volume=18&amp;publication_year=2019&amp;pages=295-317&amp;pmid=30610225&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R7"><span class="mixed-citation">Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK, O&#x02019;Brien JP, Pierce KA, et al. (2016). <span class="ref-title">Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer</span>. <span class="ref-journal">Cell Metab</span>
<span class="ref-vol">23</span>, 517&#x02013;528. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4785096/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26853747" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Environment+Impacts+the+Metabolic+Dependencies+of+Ras-Driven+Non-Small+Cell+Lung+Cancer&amp;author=SM+Davidson&amp;author=T+Papagiannakopoulos&amp;author=BA+Olenchock&amp;author=JE+Heyman&amp;author=MA+Keibler&amp;volume=23&amp;publication_year=2016&amp;pages=517-528&amp;pmid=26853747&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R8"><span class="mixed-citation">Davies TG, Wixted WE, Coyle JE, Griffiths-Jones C, Hearn K, McMenamin R, Norton D,Rich SJ, Richardson C, Saxty G, et al. (2016). <span class="ref-title">Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery</span>. <span class="ref-journal">Journal of medicinal chemistry</span>
<span class="ref-vol">59</span>, 3991&#x02013;4006. [<a href="https://pubmed.ncbi.nlm.nih.gov/27031670" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+medicinal+chemistry&amp;title=Monoacidic+Inhibitors+of+the+Kelch-like+ECH-Associated+Protein+1:+Nuclear+Factor+Erythroid+2-Related+Factor+2+(KEAP1:NRF2)+Protein-Protein+Interaction+with+High+Cell+Potency+Identified+by+Fragment-Based+Discovery&amp;author=TG+Davies&amp;author=WE+Wixted&amp;author=JE+Coyle&amp;author=C+Griffiths-Jones&amp;author=K+Hearn&amp;volume=59&amp;publication_year=2016&amp;pages=3991-4006&amp;pmid=27031670&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R9"><span class="mixed-citation">DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, and Thompson CB (2007). <span class="ref-title">Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>
<span class="ref-vol">104</span>, 19345&#x02013;19350. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2148292/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18032601" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Beyond+aerobic+glycolysis:+transformed+cells+can+engage+in+glutamine+metabolism+that+exceeds+the+requirement+for+protein+and+nucleotide+synthesis&amp;author=RJ+DeBerardinis&amp;author=A+Mancuso&amp;author=E+Daikhin&amp;author=I+Nissim&amp;author=M+Yudkoff&amp;volume=104&amp;publication_year=2007&amp;pages=19345-19350&amp;pmid=18032601&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R10"><span class="mixed-citation">DeNicola GM, and Cantley LC (2015). <span class="ref-title">Cancer&#x02019;s Fuel Choice: New Flavors for a Picky Eater</span>. <span class="ref-journal">Molecular cell</span>
<span class="ref-vol">60</span>, 514&#x02013;523. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4676726/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26590711" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+cell&amp;title=Cancer&#x02019;s+Fuel+Choice:+New+Flavors+for+a+Picky+Eater&amp;author=GM+DeNicola&amp;author=LC+Cantley&amp;volume=60&amp;publication_year=2015&amp;pages=514-523&amp;pmid=26590711&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R11"><span class="mixed-citation">DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D, Tang H, Xie Y, Asara JM, Huffman KE, et al. (2015). <span class="ref-title">NRF2 regulates serine biosynthesis in non-small cell lung cancer</span>. <span class="ref-journal">Nat Genet</span>
<span class="ref-vol">47</span>, 1475&#x02013;1481. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4721512/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26482881" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=NRF2+regulates+serine+biosynthesis+in+non-small+cell+lung+cancer&amp;author=GM+DeNicola&amp;author=PH+Chen&amp;author=E+Mullarky&amp;author=JA+Sudderth&amp;author=Z+Hu&amp;volume=47&amp;publication_year=2015&amp;pages=1475-1481&amp;pmid=26482881&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R12"><span class="mixed-citation">DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, et al. (2011). <span class="ref-title">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">475</span>, 106. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3404470/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21734707" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Oncogene-induced+Nrf2+transcription+promotes+ROS+detoxification+and+tumorigenesis&amp;author=GM+DeNicola&amp;author=FA+Karreth&amp;author=TJ+Humpton&amp;author=A+Gopinathan&amp;author=C+Wei&amp;volume=475&amp;publication_year=2011&amp;pages=106&amp;pmid=21734707&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R13"><span class="mixed-citation">Diehl FF, Lewis CA, Fiske BP, and Vander Heiden MG (2019). <span class="ref-title">Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation</span>. <span class="ref-journal">Nature Metabolism</span>
<span class="ref-vol">1</span>, 861&#x02013;867. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6785045/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31598584" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Metabolism&amp;title=Cellular+redox+state+constrains+serine+synthesis+and+nucleotide+production+to+impact+cell+proliferation&amp;author=FF+Diehl&amp;author=CA+Lewis&amp;author=BP+Fiske&amp;author=MG+Vander+Heiden&amp;volume=1&amp;publication_year=2019&amp;pages=861-867&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R14"><span class="mixed-citation">Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong RM, Miller KM, Bendor J, and Jacks T (2016). <span class="ref-title">Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development</span>. <span class="ref-journal">Cancer Discov</span>
<span class="ref-vol">6</span>, 188&#x02013;201. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4744583/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26586766" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Discov&amp;title=Stromal+Expression+of+miR-143/145+Promotes+Neoangiogenesis+in+Lung+Cancer+Development&amp;author=N+Dimitrova&amp;author=V+Gocheva&amp;author=A+Bhutkar&amp;author=R+Resnick&amp;author=RM+Jong&amp;volume=6&amp;publication_year=2016&amp;pages=188-201&amp;pmid=26586766&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R15"><span class="mixed-citation">Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, et al. (2014). <span class="ref-title">Pharmacological inhibition of cysteine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis</span>. <span class="ref-journal">Elife</span>
<span class="ref-vol">3</span>, e02523. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4054777/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24844246" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Pharmacological+inhibition+of+cysteine-glutamate+exchange+induces+endoplasmic+reticulum+stress+and+ferroptosis&amp;author=SJ+Dixon&amp;author=DN+Patel&amp;author=M+Welsch&amp;author=R+Skouta&amp;author=ED+Lee&amp;volume=3&amp;publication_year=2014&amp;pages=e02523&amp;pmid=24844246&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R16"><span class="mixed-citation">Elia I, Broekaert D, Christen S, Boon R, Radaelli E, Orth MF, Verfaillie C, Grunewald TGP, and Fendt SM (2017). <span class="ref-title">Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells</span>. <span class="ref-journal">Nat Commun</span>
<span class="ref-vol">8</span>, 15267. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5437289/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28492237" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Proline+metabolism+supports+metastasis+formation+and+could+be+inhibited+to+selectively+target+metastasizing+cancer+cells&amp;author=I+Elia&amp;author=D+Broekaert&amp;author=S+Christen&amp;author=R+Boon&amp;author=E+Radaelli&amp;volume=8&amp;publication_year=2017&amp;pages=15267&amp;pmid=28492237&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R17"><span class="mixed-citation">Fernandez CA, Des Rosiers C, Previs SF, David F, and Brunengraber H (1996). <span class="ref-title">Correction of 13C mass isotopomer distributions for natural stable isotope abundance</span>. <span class="ref-journal">Journal of mass spectrometry : JMS</span>
<span class="ref-vol">31</span>, 255&#x02013;262. [<a href="https://pubmed.ncbi.nlm.nih.gov/8799277" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+mass+spectrometry+:+JMS&amp;title=Correction+of+13C+mass+isotopomer+distributions+for+natural+stable+isotope+abundance&amp;author=CA+Fernandez&amp;author=C+Des+Rosiers&amp;author=SF+Previs&amp;author=F+David&amp;author=H+Brunengraber&amp;volume=31&amp;publication_year=1996&amp;pages=255-262&amp;pmid=8799277&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R18"><span class="mixed-citation">Fox DB, Lupo R, Noteware LC, Newcomb R, Liu J, Locasale JW, Hirschey MD, and Alvarez JV (2019). <span class="ref-title">NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition</span>. <span class="ref-journal">bioRxiv</span>, <span class="ref-vol">513994</span>. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=bioRxiv&amp;title=NRF2-dependent+metabolic+reprogramming+is+required+for+tumor+recurrence+following+oncogene+inhibition&amp;author=DB+Fox&amp;author=R+Lupo&amp;author=LC+Noteware&amp;author=R+Newcomb&amp;author=J+Liu&amp;volume=513994&amp;publication_year=2019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R19"><span class="mixed-citation">Gao X, Sanderson SM, Dai Z, Reid MA, Cooper DE, Lu M, Richie JP Jr., Ciccarella A, Calcagnotto A, Mikhael PG, et al. (2019). <span class="ref-title">Dietary methionine influences therapy in mouse cancer models and alters human metabolism</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">572</span>, 397&#x02013;401. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6951023/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31367041" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Dietary+methionine+influences+therapy+in+mouse+cancer+models+and+alters+human+metabolism&amp;author=X+Gao&amp;author=SM+Sanderson&amp;author=Z+Dai&amp;author=MA+Reid&amp;author=DE+Cooper&amp;volume=572&amp;publication_year=2019&amp;pages=397-401&amp;pmid=31367041&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R20"><span class="mixed-citation">Garcia-Bermudez J, Baudrier L, La K, Zhu XG, Fidelin J, Sviderskiy VO, Papagiannakopoulos T, Molina H, Snuderl M, Lewis CA, et al. (2018). <span class="ref-title">Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours</span>. <span class="ref-journal">Nat Cell Biol</span>
<span class="ref-vol">20</span>, 775&#x02013;781. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6030478/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29941933" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Cell+Biol&amp;title=Aspartate+is+a+limiting+metabolite+for+cancer+cell+proliferation+under+hypoxia+and+in+tumours&amp;author=J+Garcia-Bermudez&amp;author=L+Baudrier&amp;author=K+La&amp;author=XG+Zhu&amp;author=J+Fidelin&amp;volume=20&amp;publication_year=2018&amp;pages=775-781&amp;pmid=29941933&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R21"><span class="mixed-citation">Griffith OW, and Meister A (1979). <span class="ref-title">Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">254</span>, 7558&#x02013;7560. [<a href="https://pubmed.ncbi.nlm.nih.gov/38242" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Potent+and+specific+inhibition+of+glutathione+synthesis+by+buthionine+sulfoximine+(S-n-butyl+homocysteine+sulfoximine)&amp;author=OW+Griffith&amp;author=A+Meister&amp;volume=254&amp;publication_year=1979&amp;pages=7558-7560&amp;pmid=38242&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R22"><span class="mixed-citation">Gwinn DM, Lee AG, Briones-Martin-Del-Campo M, Conn CS, Simpson DR, Scott AI, Le A, Cowan TM, Ruggero D, and Sweet-Cordero EA (2018). <span class="ref-title">Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase</span>. <span class="ref-journal">Cancer Cell</span>
<span class="ref-vol">33</span>, 91&#x02013;107.e106. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5761662/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29316436" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=Oncogenic+KRAS+Regulates+Amino+Acid+Homeostasis+and+Asparagine+Biosynthesis+via+ATF4+and+Alters+Sensitivity+to+L-Asparaginase&amp;author=DM+Gwinn&amp;author=AG+Lee&amp;author=M+Briones-Martin-Del-Campo&amp;author=CS+Conn&amp;author=DR+Simpson&amp;volume=33&amp;publication_year=2018&amp;pages=91-107&amp;pmid=29316436&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R23"><span class="mixed-citation">Hanahan D, and Weinberg RA (2011). <span class="ref-title">Hallmarks of cancer: the next generation</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">144</span>, 646&#x02013;674. [<a href="https://pubmed.ncbi.nlm.nih.gov/21376230" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Hallmarks+of+cancer:+the+next+generation&amp;author=D+Hanahan&amp;author=RA+Weinberg&amp;volume=144&amp;publication_year=2011&amp;pages=646-674&amp;pmid=21376230&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R24"><span class="mixed-citation">Heiden MGV, and DeBerardinis RJ (2017). <span class="ref-title">Understanding the intersections between metabolism and cancer biology</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">168</span>, 657&#x02013;669. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5329766/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28187287" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Understanding+the+intersections+between+metabolism+and+cancer+biology&amp;author=MGV+Heiden&amp;author=RJ+DeBerardinis&amp;volume=168&amp;publication_year=2017&amp;pages=657-669&amp;pmid=28187287&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R25"><span class="mixed-citation">Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, et al. (2018). <span class="ref-title">Suppression of insulin feedback enhances the efficacy of PI3K inhibitors</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">560</span>, 499&#x02013;503. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6197057/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30051890" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Suppression+of+insulin+feedback+enhances+the+efficacy+of+PI3K+inhibitors&amp;author=BD+Hopkins&amp;author=C+Pauli&amp;author=X+Du&amp;author=DG+Wang&amp;author=X+Li&amp;volume=560&amp;publication_year=2018&amp;pages=499-503&amp;pmid=30051890&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R26"><span class="mixed-citation">Knott SRV, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, Turgeon MO, Fish L, Erard N, Gable AL, et al. (2018). <span class="ref-title">Asparagine bioavailability governs metastasis in a model of breast cancer</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">554</span>, 378&#x02013;381. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5898613/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29414946" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Asparagine+bioavailability+governs+metastasis+in+a+model+of+breast+cancer&amp;author=SRV+Knott&amp;author=E+Wagenblast&amp;author=S+Khan&amp;author=SY+Kim&amp;author=M+Soto&amp;volume=554&amp;publication_year=2018&amp;pages=378-381&amp;pmid=29414946&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R27"><span class="mixed-citation">Koppula P, Zhang Y, Shi J, Li W, and Gan B (2017). <span class="ref-title">The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">292</span>, 14240&#x02013;14249. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5572906/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28630042" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+glutamate/cystine+antiporter+SLC7A11/xCT+enhances+cancer+cell+dependency+on+glucose+by+exporting+glutamate&amp;author=P+Koppula&amp;author=Y+Zhang&amp;author=J+Shi&amp;author=W+Li&amp;author=B+Gan&amp;volume=292&amp;publication_year=2017&amp;pages=14240-14249&amp;pmid=28630042&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R28"><span class="mixed-citation">Kovac M, Navas C, Horswell S, Salm M, Bardella C, Rowan A, Stares M, Castro-Giner F, Fisher R, de Bruin EC, et al. (2015). <span class="ref-title">Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution</span>. <span class="ref-journal">Nat Commun</span>
<span class="ref-vol">6</span>, 6336. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4383019/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25790038" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Recurrent+chromosomal+gains+and+heterogeneous+driver+mutations+characterise+papillary+renal+cancer+evolution&amp;author=M+Kovac&amp;author=C+Navas&amp;author=S+Horswell&amp;author=M+Salm&amp;author=C+Bardella&amp;volume=6&amp;publication_year=2015&amp;pages=6336&amp;pmid=25790038&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R29"><span class="mixed-citation">Larson SD, Li J, Chung DH, and Evers BM (2007). <span class="ref-title">Molecular mechanisms contributing to glutamine-mediated intestinal cell survival</span>. <span class="ref-journal">American journal of physiology. Gastrointestinal and liver physiology</span>
<span class="ref-vol">293</span>, G1262&#x02013;1271. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2432018/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17916648" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+journal+of+physiology.+Gastrointestinal+and+liver+physiology&amp;title=Molecular+mechanisms+contributing+to+glutamine-mediated+intestinal+cell+survival&amp;author=SD+Larson&amp;author=J+Li&amp;author=DH+Chung&amp;author=BM+Evers&amp;volume=293&amp;publication_year=2007&amp;pages=G1262-1271&amp;pmid=17916648&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R30"><span class="mixed-citation">Lehninger AL, Nelson DL, and Cox MM (2000). <span class="ref-journal">Principles of Biochemistry</span>. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Principles+of+Biochemistry&amp;author=AL+Lehninger&amp;author=DL+Nelson&amp;author=MM+Cox&amp;publication_year=2000&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R31"><span class="mixed-citation">Lewis CA, Parker SJ, Fiske BP, McCloskey D, Gui DY, Green CR, Vokes NI, Feist AM, Vander Heiden MG, and Metallo CM (2014). <span class="ref-title">Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells</span>. <span class="ref-journal">Molecular cell</span>
<span class="ref-vol">55</span>, 253&#x02013;263. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4106038/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24882210" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+cell&amp;title=Tracing+compartmentalized+NADPH+metabolism+in+the+cytosol+and+mitochondria+of+mammalian+cells&amp;author=CA+Lewis&amp;author=SJ+Parker&amp;author=BP+Fiske&amp;author=D+McCloskey&amp;author=DY+Gui&amp;volume=55&amp;publication_year=2014&amp;pages=253-263&amp;pmid=24882210&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R32"><span class="mixed-citation">Lignitto L, LeBoeuf SE, Homer H, Jiang S, Askenazi M, Karakousi TR, Pass HI, Bhutkar AJ, Tsirigos A, Ueberheide B, et al. (2019). <span class="ref-title">Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">178</span>, 316&#x02013;329.e318. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6625921/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31257023" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Nrf2+Activation+Promotes+Lung+Cancer+Metastasis+by+Inhibiting+the+Degradation+of+Bach1&amp;author=L+Lignitto&amp;author=SE+LeBoeuf&amp;author=H+Homer&amp;author=S+Jiang&amp;author=M+Askenazi&amp;volume=178&amp;publication_year=2019&amp;pages=316-329&amp;pmid=31257023&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R33"><span class="mixed-citation">Loayza-Puch F, Rooijers K, Buil LC, Zijlstra J, Oude Vrielink JF, Lopes R, Ugalde AP, van Breugel P, Hofland I, Wesseling J, et al. (2016). <span class="ref-title">Tumour-specific proline vulnerability uncovered by differential ribosome codon reading</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">530</span>, 490&#x02013;494. [<a href="https://pubmed.ncbi.nlm.nih.gov/26878238" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Tumour-specific+proline+vulnerability+uncovered+by+differential+ribosome+codon+reading&amp;author=F+Loayza-Puch&amp;author=K+Rooijers&amp;author=LC+Buil&amp;author=J+Zijlstra&amp;author=JF+Oude+Vrielink&amp;volume=530&amp;publication_year=2016&amp;pages=490-494&amp;pmid=26878238&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R34"><span class="mixed-citation">Lozoya OA, Martinez-Reyes I, Wang T, Grenet D, Bushel P, Li J, Chandel N, Woychik RP, and Santos JH (2018). <span class="ref-title">Mitochondrial nicotinamide adenine dinucleotide reduced (NADH) oxidation links the tricarboxylic acid (TCA) cycle with methionine metabolism and nuclear DNA methylation</span>. <span class="ref-journal">PLoS biology</span>
<span class="ref-vol">16</span>, e2005707. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5927466/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29668680" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+biology&amp;title=Mitochondrial+nicotinamide+adenine+dinucleotide+reduced+(NADH)+oxidation+links+the+tricarboxylic+acid+(TCA)+cycle+with+methionine+metabolism+and+nuclear+DNA+methylation&amp;author=OA+Lozoya&amp;author=I+Martinez-Reyes&amp;author=T+Wang&amp;author=D+Grenet&amp;author=P+Bushel&amp;volume=16&amp;publication_year=2018&amp;pages=e2005707&amp;pmid=29668680&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R35"><span class="mixed-citation">Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, and Vousden KH (2013). <span class="ref-title">Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">493</span>, 542&#x02013;546. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6485472/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23242140" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Serine+starvation+induces+stress+and+p53-dependent+metabolic+remodelling+in+cancer+cells&amp;author=OD+Maddocks&amp;author=CR+Berkers&amp;author=SM+Mason&amp;author=L+Zheng&amp;author=K+Blyth&amp;volume=493&amp;publication_year=2013&amp;pages=542-546&amp;pmid=23242140&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R36"><span class="mixed-citation">Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, Mackay GM, Labuschagne CF, Gay D, Kruiswijk F, et al. (2017). <span class="ref-title">Modulating the therapeutic response of tumours to dietary serine and glycine starvation</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">544</span>, 372&#x02013;376. [<a href="https://pubmed.ncbi.nlm.nih.gov/28425994" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Modulating+the+therapeutic+response+of+tumours+to+dietary+serine+and+glycine+starvation&amp;author=ODK+Maddocks&amp;author=D+Athineos&amp;author=EC+Cheung&amp;author=P+Lee&amp;author=T+Zhang&amp;volume=544&amp;publication_year=2017&amp;pages=372-376&amp;pmid=28425994&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R37"><span class="mixed-citation">Martinez-Reyes I, Diebold LP, Kong H, Schieber M, Huang H, Hensley CT, Mehta MM, Wang T, Santos JH, Woychik R, et al. (2016). <span class="ref-title">TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions</span>. <span class="ref-journal">Molecular cell</span>
<span class="ref-vol">61</span>, 199&#x02013;209. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4724312/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26725009" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+cell&amp;title=TCA+Cycle+and+Mitochondrial+Membrane+Potential+Are+Necessary+for+Diverse+Biological+Functions&amp;author=I+Martinez-Reyes&amp;author=LP+Diebold&amp;author=H+Kong&amp;author=M+Schieber&amp;author=H+Huang&amp;volume=61&amp;publication_year=2016&amp;pages=199-209&amp;pmid=26725009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R38"><span class="mixed-citation">Mehrmohamadi M, and Locasale JW (2015). <span class="ref-title">Context dependent utilization of serine in cancer</span>. <span class="ref-journal">Molecular &#x00026; cellular oncology</span>
<span class="ref-vol">2</span>, e996418. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4635483/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26550606" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+&#x00026;+cellular+oncology&amp;title=Context+dependent+utilization+of+serine+in+cancer&amp;author=M+Mehrmohamadi&amp;author=JW+Locasale&amp;volume=2&amp;publication_year=2015&amp;pages=e996418&amp;pmid=26550606&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R39"><span class="mixed-citation">Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C, and Jacks T (2009). <span class="ref-title">Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">462</span>, 104&#x02013;107. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2780341/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19847165" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Requirement+for+NF-kappaB+signalling+in+a+mouse+model+of+lung+adenocarcinoma&amp;author=E+Meylan&amp;author=AL+Dooley&amp;author=DM+Feldser&amp;author=L+Shen&amp;author=E+Turk&amp;volume=462&amp;publication_year=2009&amp;pages=104-107&amp;pmid=19847165&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R40"><span class="mixed-citation">Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, and Motohashi H (2012). <span class="ref-title">Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming</span>. <span class="ref-journal">Cancer Cell</span>
<span class="ref-vol">22</span>, 66&#x02013;79. [<a href="https://pubmed.ncbi.nlm.nih.gov/22789539" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=Nrf2+redirects+glucose+and+glutamine+into+anabolic+pathways+in+metabolic+reprogramming&amp;author=Y+Mitsuishi&amp;author=K+Taguchi&amp;author=Y+Kawatani&amp;author=T+Shibata&amp;author=T+Nukiwa&amp;volume=22&amp;publication_year=2012&amp;pages=66-79&amp;pmid=22789539&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R41"><span class="mixed-citation">Muir A, Danai LV, Gui DY, Waingarten CY, Lewis CA, and Vander Heiden MG (2017). <span class="ref-title">Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition</span>. <span class="ref-journal">Elife</span>
<span class="ref-vol">6</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5589418/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28826492" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Environmental+cystine+drives+glutamine+anaplerosis+and+sensitizes+cancer+cells+to+glutaminase+inhibition&amp;author=A+Muir&amp;author=LV+Danai&amp;author=DY+Gui&amp;author=CY+Waingarten&amp;author=CA+Lewis&amp;volume=6&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R42"><span class="mixed-citation">Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, et al. (2009). <span class="ref-title">Bidirectional transport of amino acids regulates mTOR and autophagy</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">136</span>, 52&#x02013;534. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3733119/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19203585" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Bidirectional+transport+of+amino+acids+regulates+mTOR+and+autophagy&amp;author=P+Nicklin&amp;author=P+Bergman&amp;author=B+Zhang&amp;author=E+Triantafellow&amp;author=H+Wang&amp;volume=136&amp;publication_year=2009&amp;pages=52-534&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R43"><span class="mixed-citation">Reid MA, Allen AE, Liu S, Liberti MV, Liu P, Liu X, Dai Z, Gao X, Wang Q, Liu Y, et al. (2018). <span class="ref-title">Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism</span>. <span class="ref-journal">Nat Commun</span>
<span class="ref-vol">9</span>, 5442. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6303315/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30575741" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Serine+synthesis+through+PHGDH+coordinates+nucleotide+levels+by+maintaining+central+carbon+metabolism&amp;author=MA+Reid&amp;author=AE+Allen&amp;author=S+Liu&amp;author=MV+Liberti&amp;author=P+Liu&amp;volume=9&amp;publication_year=2018&amp;pages=5442&amp;pmid=30575741&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R44"><span class="mixed-citation">Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, Berschneider HM, and Brenner DA (1997). <span class="ref-title">L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases</span>. <span class="ref-journal">The American journal of physiology</span>
<span class="ref-vol">272</span>, G943&#x02013;953. [<a href="https://pubmed.ncbi.nlm.nih.gov/9176200" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+American+journal+of+physiology&amp;title=L-glutamine+stimulates+intestinal+cell+proliferation+and+activates+mitogen-activated+protein+kinases&amp;author=JM+Rhoads&amp;author=RA+Argenzio&amp;author=W+Chen&amp;author=RA+Rippe&amp;author=JK+Westwick&amp;volume=272&amp;publication_year=1997&amp;pages=G943-953&amp;pmid=9176200&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R45"><span class="mixed-citation">Richards NG, and Kilberg MS (2006). <span class="ref-title">Asparagine synthetase chemotherapy</span>. <span class="ref-journal">Annu Rev Biochem</span>
<span class="ref-vol">75</span>, 629&#x02013;654. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3587692/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16756505" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;title=Asparagine+synthetase+chemotherapy&amp;author=NG+Richards&amp;author=MS+Kilberg&amp;volume=75&amp;publication_year=2006&amp;pages=629-654&amp;pmid=16756505&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R46"><span class="mixed-citation">Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sanchez-Rivera FJ, et al. (2017). <span class="ref-title">Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis</span>. <span class="ref-journal">Nat Med</span>
<span class="ref-vol">23</span>, 1362&#x02013;1368. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5677540/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28967920" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Keap1+loss+promotes+Kras-driven+lung+cancer+and+results+in+dependence+on+glutaminolysis&amp;author=R+Romero&amp;author=VI+Sayin&amp;author=SM+Davidson&amp;author=MR+Bauer&amp;author=SX+Singh&amp;volume=23&amp;publication_year=2017&amp;pages=1362-1368&amp;pmid=28967920&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R47"><span class="mixed-citation">Santidrian AF, LeBoeuf SE, Wold ED, Ritland M, Forsyth JS, and Felding BH (2014). <span class="ref-title">Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer</span>. <span class="ref-journal">DNA repair</span>
<span class="ref-vol">23</span>, 79&#x02013;87. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4252795/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25263164" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=DNA+repair&amp;title=Nicotinamide+phosphoribosyltransferase+can+affect+metastatic+activity+and+cell+adhesive+functions+by+regulating+integrins+in+breast+cancer&amp;author=AF+Santidrian&amp;author=SE+LeBoeuf&amp;author=ED+Wold&amp;author=M+Ritland&amp;author=JS+Forsyth&amp;volume=23&amp;publication_year=2014&amp;pages=79-87&amp;pmid=25263164&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R48"><span class="mixed-citation">Sayin VI, LeBoeuf SE, Singh SX, Davidson SM, Biancur D, Guzelhan BS, Alvarez SW, Wu WL, Karakousi TR, Zavitsanou AM, et al. (2017). <span class="ref-title">Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer</span>. <span class="ref-journal">Elife</span>
<span class="ref-vol">6</span>. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5624783/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28967864" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Activation+of+the+NRF2+antioxidant+program+generates+an+imbalance+in+central+carbon+metabolism+in+cancer&amp;author=VI+Sayin&amp;author=SE+LeBoeuf&amp;author=SX+Singh&amp;author=SM+Davidson&amp;author=D+Biancur&amp;volume=6&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R49"><span class="mixed-citation">Shin CS, Mishra P, Watrous JD, Carelli V, D&#x02019;Aurelio M, Jain M, and Chan DC (2017). <span class="ref-title">The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility</span>. <span class="ref-journal">Nat Commun</span>
<span class="ref-vol">8</span>, 15074. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5413954/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28429737" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=The+glutamate/cystine+xCT+antiporter+antagonizes+glutamine+metabolism+and+reduces+nutrient+flexibility&amp;author=CS+Shin&amp;author=P+Mishra&amp;author=JD+Watrous&amp;author=V+Carelli&amp;author=M+D&#x02019;Aurelio&amp;volume=8&amp;publication_year=2017&amp;pages=15074&amp;pmid=28429737&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R50"><span class="mixed-citation">Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, Kremer D, Hwang RF, Witkiewicz AK, Ying H, et al. (2016). <span class="ref-title">Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">536</span>, 479&#x02013;483. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5228623/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27509858" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Pancreatic+stellate+cells+support+tumour+metabolism+through+autophagic+alanine+secretion&amp;author=CM+Sousa&amp;author=DE+Biancur&amp;author=X+Wang&amp;author=CJ+Halbrook&amp;author=MH+Sherman&amp;volume=536&amp;publication_year=2016&amp;pages=479-483&amp;pmid=27509858&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R51"><span class="mixed-citation">Storck T, Schulte S, Hofmann K, and Stoffel W (1992). <span class="ref-title">Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain</span>. <span class="ref-journal">Proc Natl Acad Sci U S A</span>
<span class="ref-vol">89</span>, 10955&#x02013;10959. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC50461/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1279699" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Structure,+expression,+and+functional+analysis+of+a+Na(+)-dependent+glutamate/aspartate+transporter+from+rat+brain&amp;author=T+Storck&amp;author=S+Schulte&amp;author=K+Hofmann&amp;author=W+Stoffel&amp;volume=89&amp;publication_year=1992&amp;pages=10955-10959&amp;pmid=1279699&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R52"><span class="mixed-citation">Sullivan LB, Luengo A, Danai LV, Bush LN, Diehl FF, Hosios AM, Lau AN, Elmiligy S, Malstrom S, Lewis CA, et al. (2018). <span class="ref-title">Aspartate is an endogenous metabolic limitation for tumour growth</span>. <span class="ref-journal">Nature Cell Biology</span>
<span class="ref-vol">20</span>, 782&#x02013;788. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6051729/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29941931" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Cell+Biology&amp;title=Aspartate+is+an+endogenous+metabolic+limitation+for+tumour+growth&amp;author=LB+Sullivan&amp;author=A+Luengo&amp;author=LV+Danai&amp;author=LN+Bush&amp;author=FF+Diehl&amp;volume=20&amp;publication_year=2018&amp;pages=782-788&amp;pmid=29941931&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R53"><span class="mixed-citation">Tsun ZY, and Possemato R (2015). <span class="ref-title">Amino acid management in cancer</span>. <span class="ref-journal">Semin Cell Dev Biol</span>
<span class="ref-vol">43</span>, 22&#x02013;32. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4800996/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26277542" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Cell+Dev+Biol&amp;title=Amino+acid+management+in+cancer&amp;author=ZY+Tsun&amp;author=R+Possemato&amp;volume=43&amp;publication_year=2015&amp;pages=22-32&amp;pmid=26277542&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R54"><span class="mixed-citation">Umbarger HE (1978). <span class="ref-title">Amino acid biosynthesis and its regulation</span>. <span class="ref-journal">Annu Rev Biochem</span>
<span class="ref-vol">47</span>, 532&#x02013;606. [<a href="https://pubmed.ncbi.nlm.nih.gov/354503" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;title=Amino+acid+biosynthesis+and+its+regulation&amp;author=HE+Umbarger&amp;volume=47&amp;publication_year=1978&amp;pages=532-606&amp;pmid=354503&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R55"><span class="mixed-citation">Urig S, and Becker K (2006). <span class="ref-title">On the potential of thioredoxin reductase inhibitors for cancer therapy</span>. <span class="ref-journal">Seminars in cancer biology</span>
<span class="ref-vol">16</span>, 452&#x02013;465. [<a href="https://pubmed.ncbi.nlm.nih.gov/17056271" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Seminars+in+cancer+biology&amp;title=On+the+potential+of+thioredoxin+reductase+inhibitors+for+cancer+therapy&amp;author=S+Urig&amp;author=K+Becker&amp;volume=16&amp;publication_year=2006&amp;pages=452-465&amp;pmid=17056271&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R56"><span class="mixed-citation">Vander Heiden MG, Cantley LC, and Thompson CB (2009). <span class="ref-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span>. <span class="ref-journal">Science (New York, N.Y.)</span>
<span class="ref-vol">324</span>, 1029&#x02013;1033. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2849637/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19460998" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science+(New+York,+N.Y.)&amp;title=Understanding+the+Warburg+effect:+the+metabolic+requirements+of+cell+proliferation&amp;author=MG+Vander+Heiden&amp;author=LC+Cantley&amp;author=CB+Thompson&amp;volume=324&amp;publication_year=2009&amp;pages=1029-1033&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R57"><span class="mixed-citation">Wang Q, Chuikov S, Taitano S, Wu Q, Rastogi A, Tuck SJ, Corey JM, Lundy SK, and Mao-Draayer Y (2015). <span class="ref-title">Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway</span>. <span class="ref-journal">International Journal of Molecular Sciences</span>
<span class="ref-vol">16</span>, 13885&#x02013;13907. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4490529/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26090715" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Journal+of+Molecular+Sciences&amp;title=Dimethyl+Fumarate+Protects+Neural+Stem/Progenitor+Cells+and+Neurons+from+Oxidative+Damage+through+Nrf2-ERK1/2+MAPK+Pathway&amp;author=Q+Wang&amp;author=S+Chuikov&amp;author=S+Taitano&amp;author=Q+Wu&amp;author=A+Rastogi&amp;volume=16&amp;publication_year=2015&amp;pages=13885-13907&amp;pmid=26090715&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R58"><span class="mixed-citation">Watanabe H, and Bannai S (1987). <span class="ref-title">Induction of cystine transport activity in mouse peritoneal macrophages</span>. <span class="ref-journal">The Journal of experimental medicine</span>
<span class="ref-vol">165</span>, 628&#x02013;640. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2188288/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2880923" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+experimental+medicine&amp;title=Induction+of+cystine+transport+activity+in+mouse+peritoneal+macrophages&amp;author=H+Watanabe&amp;author=S+Bannai&amp;volume=165&amp;publication_year=1987&amp;pages=628-640&amp;pmid=2880923&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R59"><span class="mixed-citation">Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, et al. (2014). <span class="ref-title">Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis</span>. <span class="ref-journal">Elife</span>
<span class="ref-vol">3</span>, e02242. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4017650/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24843020" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Metformin+inhibits+mitochondrial+complex+I+of+cancer+cells+to+reduce+tumorigenesis&amp;author=WW+Wheaton&amp;author=SE+Weinberg&amp;author=RB+Hamanaka&amp;author=S+Soberanes&amp;author=LB+Sullivan&amp;volume=3&amp;publication_year=2014&amp;pages=e02242&amp;pmid=24843020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R60"><span class="mixed-citation">Yagi T, Seo BB, Nakamaru-Ogiso E, Marella M, Barber-Singh J, Yamashita T, Kao MC, and Matsuno-Yagi A (2006). <span class="ref-title">Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?</span>
<span class="ref-journal">Rejuvenation research</span>
<span class="ref-vol">9</span>, 191&#x02013;197. [<a href="https://pubmed.ncbi.nlm.nih.gov/16706641" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rejuvenation+research&amp;title=Can+a+single+subunit+yeast+NADH+dehydrogenase+(Ndi1)+remedy+diseases+caused+by+respiratory+complex+I+defects?&amp;author=T+Yagi&amp;author=BB+Seo&amp;author=E+Nakamaru-Ogiso&amp;author=M+Marella&amp;author=J+Barber-Singh&amp;volume=9&amp;publication_year=2006&amp;pages=191-197&amp;pmid=16706641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="R61"><span class="mixed-citation">Yang M, and Vousden KH (2016). <span class="ref-title">Serine and one-carbon metabolism in cancer</span>. <span class="ref-journal">Nat Rev Cancer</span>
<span class="ref-vol">16</span>, 650&#x02013;662. [<a href="https://pubmed.ncbi.nlm.nih.gov/27634448" ref="reftype=pubmed&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Serine+and+one-carbon+metabolism+in+cancer&amp;author=M+Yang&amp;author=KH+Vousden&amp;volume=16&amp;publication_year=2016&amp;pages=650-662&amp;pmid=27634448&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=7004873&amp;issue-id=351862&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC7004873/pdf/nihms-1545176.pdf" class="int-view">PDF (2.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/7004873/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/7004873/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="7004873" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004873%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="Q9sl4ZCuc7jLOvrf7ypPTyEK353Wd4G5qdkC4P3eurSDIFW47Ejo0qWQZxfdCIWv">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004873%2F&amp;text=Activation%20of%20oxidative%20stress%20response%20in%20cancer%20generates%20a%20druggable%20dependency%20on%20exogenous%20non-essential%20amino%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7004873%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004873/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC7004873/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/31813821/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC7004873/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/31813821/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC7004873/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/7004873/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC7004873/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
